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ABSTRACT
Clinical evaluation of cancer therapeutics often involves a series of measurements of
multiple tumor diameters. While a growing number of research studies have reported interobserver variability in computed tomographic (CT) measurements among radiologists,
there are very few interventional studies performed to reduce the variability. Furthermore,
it remains unclear whether use of conventional statistical measures in evaluating the CT
measurement variability is appropriate. A data-mining tool that can extract the tumor
burden information from raw CT images has the potential to assist radiologists in reducing
inter-observer variability.

In this dissertation, I present (1) a new measure to evaluating inter-observer variability in
CT measurement of cancer lesions, (2) a peer benchmarking intervention designed to
reduce the variability, and (3) deep learning frameworks for semi-automated measurement
of solid tumors. First, 13 board-certified radiologists from Prisma Health repeatedly
reviewed the same CT image sets of lung lesions and hepatic metastases during three noncontiguous time periods (T1, T2, T3). The intervention tool was presented to the
radiologists prior to T3. Various analytical methods were employed to assess the
performance of the proposed measure and peer benchmarking intervention tool. Next, a
total of 1,506 CT slices selected from 465,152 CT slices were reviewed and measured by
three experienced radiologists for training deep learning classifiers. The deep neural
network classifiers were trained for binary classification of cancer lesions with size larger
or smaller than 32 pixels within a 128 x 128 pixel frame, and final measurement was
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produced by converting multiple classification results to magnitude in centimeters. The
inter-observer variability between a human radiologist and the proposed tool was lower
than the inter-observer variability between human radiologists.
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CHAPTER ONE
INTRODUCTION
Overview

Cancer is a group of diseases caused by an uncontrolled growth and spread of
abnormal cells, which can result in death. Cancer has been the leading cause of death in
many regions of the world as well as United States. About 606,880 Americans are expected
to die from cancer in 2019, which can be translated into about 1,663 deaths per day (Siegel,
Miller, & Jemal, 2019). Cancer is currently the second leading cause of death in the US,
followed by cardiovascular disease (Murphy, Xu, Kochanek, & Arias, 2018). With
advances in cancer treatment, the number of cancer patients who survived for more than
five years continues to increase in the United States (Kiserud, Dahl, Loge, & Fossa, 2014;
K. D. Miller et al., 2019).
The recent advances in cancer treatment have resulted in increased number of
different treatment options available for cancer patients. Most cancer patients nowadays
receive combination of multiple cancer treatments such as tumor removal surgery with
chemotherapy and/or immunotherapy (Zhang & Chen, 2018). With a number of treatment
options available, the selection of optimal treatment option requires highly precise
evaluation of treatment response at every stage of cancer treatment. Oncologists heavily
rely treatment response evaluation from radiologists for evidence of clinical efficacy of
therapy when determining whether to continue the treatment or consider alternative
treatment (K. M. Krajewski et al., 2014). The precise evaluation of cancer treatment
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response is also important in many clinical trials with new cancer treatments. While the
cancer treatment evaluation is always the major interest of cancer patients and their family,
the evaluation is challenging task which involves a number of factors to be considered.

History of Cancer Treatment Response Evaluation

The response evaluation of cancer treatment has a long history which started nearly
half the century ago. Early attempts to standardize the evaluation of treatment response of
tumor to anticancer drugs were made in 1960s with the emergence of the concept of
chemotherapy (P. Therasse et al., 2000). In 1970s, the necessity of objective assessment of
tumor treatment response were widely acknowledged. A number of different
standardizations were adopted by some radiologists as a part of their efforts to report the
evaluation of cancer treatment in a more consistent manner. The World Health
Organization (WHO) criteria for the evaluation of cancer treatment response were
published in the 1979 WHO Handbook, which served as the most predominant criteria by
radiologists in 1980s (A. B. Miller, Hoogstraten, Staquet, & Winkler, 1981). While the
WHO criteria were the first major step toward the standardization of treatment response
evaluation in cancer clinics, there were multiple issues raised by radiologists over time with
the wide spread of the WHO criteria (Ollivier, Padhani, & Leclère, 2001). First, many
radiologists felt that the definition of 'measurable' or 'evaluable' target lesion was not clear
enough and prone to subjectivity. This resulted in different interpretation of measurability
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of target lesion among different radiologist groups. Second, the number of target lesions to
be followed throughout treatment was not clearly defined. The ambiguity in the number of
target lesions resulted in the third issue; some radiologists followed a single primary target
lesion (e.g. diameter of a single largest tumor) while others target multiple lesions by
calculating overall tumor burden (e.g. sum of diameters of 5 largest lesions). Lastly, the
criteria were not designed for three-dimensional imaging such as Computed Tomography
(CT) or Magnetic Resonance Imaging (MRI)
These issues have led to the development of guidelines that may lead to more
uniform evaluation and reporting of outcomes of cancer therapeutics. In response to the
challenges presented by WHO criteria, an International Working Party, named Response
Evaluation Criteria in Solid Tumors (RECIST) Working Group, was founded in the mid
1990s to further standardize the existing response criteria. New criteria, named RECIST
criteria, were published in February 2000. The initial version of RECIST guideline
suggested several key features including detailed definitions of measurability of lesions,
minimum size of measurable lesions, detailed instructions on the number of lesions to be
tracked (e.g. 10 target lesions per organ). The guideline recommended the use of
unidimensional measurement, rather than bidimensional measurement, when assessing the
overall evaluation of tumor burden, Figure 1.1. since the RECIST criteria were published
in 2000, many investigators have adopted the guideline and confirmed that the criteria
perform reasonably well in solid tumor treatment management (E. A. Eisenhauer et al.,
2009).
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Problem Statement

While the RECIST guideline is designed for a standardized approach to solid tumor
measurement as well as objective assessment of change in size of targeted tumors, there is
still a significant room for inconsistency in the CT measurement among radiologists. For
example, the criteria state that the longest diameter of the lesion should always be measured
even if the actual axis is different from the one used to measure the lesion initially, (L. H.
Schwartz et al., 2016). The choice of axis that yields the longest diameter can also vary
among radiologists, which causes potential inter-observer variability, Figure 1.2a.
Additionally, measuring tumor diameter involves choices of start point, end point, and axis
of the measurement, which can also vary among radiologists depends on how to interpret
anatomic structure of the presented target lesion, Figure 1.2b. In case of benign tumor with
no surrounding tissue invaded, choice of axis can be highly consistent among radiologists
with reduced inter-observer variability in the final measurement. However, in case of
malignant tumor, the optimal choice of axis can be controversial among radiologists, which
may result in a significant inter-observer variability in measurement. Overall, while
measurability and number of target lesions to be followed have been clearly addressed in
the guideline, acquisition of the longest measurement relies on interpretation of anatomic
structure of the target lesion.
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Figure 1.1 Example of bidirectional measurement (left) and unidirectional measurement
(right)
(a)

¶
b.

(b)

Figure 1.2 (a) Example of different choice of longest axis (b) Example of varying choice
of start point, end point, and measurement axis

5

CHAPTER TWO
LITERATURE REVIEW

Most studies investigating inter-observer variability in treatment response
evaluation focused on inter-observer variability at a single measurement level. According
to RECIST 1.1 guideline, a progression of the disease is defined as a 20% increase in the
sum of target lesion measurements (E. A. Eisenhauer et al., 2009; L. H. Schwartz et al.,
2016). The inter-observer variability in lesion measurement is closely linked to interobserver variability in treatment response evaluation and thus has been the most common
marker in the relevant literature.

Inter-observer Variability in CT Measurement

Many studies used statistical correlation coefficient-based measures such as
intraclass correlation coefficient (ICC) and Pearson product-moment correlation
coefficient to quantify the inter-observer variability in CT measurement. The largest study
was performed by McErlean et al. to assess inter- and intra-variability of CT measurements
of lesions of various sizes in several organs including lung and liver (A. McErlean et al.,
2013). In the study, 17 radiologists measured 320 lesions on CT images during two noncontiguous time periods, which generated a total of 10,880 bidimensional measurements.
The inter-observer agreement rate based on ICC score was 0.954 in longest-axis
measurements for all radiologists who participated in the study. While the agreement rate
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was higher among senior radiologists (ICC= 0.965) than fellows (ICC=0.943), both groups
presented considerably high ICC scores. Likewise, the intra-observer variability was
considerably low with ICC scores as high as 0.970. Based on the scores, the researchers
concluded that the inter-observer variability in CT measurement is negligible and thus
serial CT measurements can be safely performed by different radiologists.
These findings correspond to the findings from other studies that used statistical
correlation coefficient as a primary measure of inter-observer measurement variability. In
the similar study conducted by Gietema et al., a total of 430 CT images containing lung
nodule measurable under guidelines were retrospectively reviewed by two radiologists.
(Gietema et al., 2006). The inter-observer variability based on spearman correlation
coefficient was 0.990 between the radiologists. Despite the high correlation coefficient
score, the study identified several cases where measurement discrepancies between the two
radiologists were observed. The potential cause of the variability was identified as
incomplete segmentation performed by the software used for the measurement. The authors
further identified that the incomplete segmentation was attributed to an irregular shape or
margins presented by the target nodules.
Another study using statistical correlation coefficients also reported unduly high
scores ranging from 0.96 to 0.99 and also concluded that CT measurements are well
reproducible with no concern for inter-observer variability (B. Zhao et al., 2009). The study
included a total of 32 non-small cell lung lesions which were retrospectively and
independently reviewed by 3 radiologists. The study recruited 32 patients who had nonsmall cell lung cancer and agreed to undergo two CT scans of chest twice within the same
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day. The participating radiologists reviewed the same set of images (64 sets of CT scans)
and were blinded to the fact that these were repeated CT scans. The same group of
radiologists were asked to measure the same set of CT scans few days later, as a part of the
effort to evaluate intra-observer variability in CT measurement along with the interobserver variability. It is also noteworthy that the radiologists were asked to perform both
unidimensional and bidimensional measurements. Bland-Altman plotting indicated that the
intra-observer variability was considerably low with only few measurements outside the
limits of agreement.
While various statistical correlation coefficients were adopted as a primary measure
in major studies on inter-observer variability in CT measurement, Hopper et al. performed
the similar study and evaluated inter-observer variability using a simple percent difference
in CT measurements between different observers (Hopper et al., 1996). In the study, interobserver variability in CT measurement ranged from 3% to 15%, which was not negligible
given the 20% progression rule suggested by RECIST guideline. The study included 24
combined thoracic and abdominal CT scans from patients with metastatic tumor. The same
set of CT scans were independently reviewed 3 radiologists. While the participating
radiologists were presented with the same set of CT scans, the scans did not contain any
information on the potential target (indicator) lesions; the radiologists were asked to
identify the indicator lesions based on own judgement. With the up to 8 foci identified for
each patient case, a total of 132 lesions were identified by at least one radiologist
throughout the study. The researchers suggested that the different choice of indicator
lesions may be the primary cause for the inter-observer variability in CT measurement.
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Also, the researchers concluded that, when interpreting follow-up CT scans of a cancer
patient, the interpreting radiologist is recommended to re-measure the target lesions from
the previous scans before proceeding to the follow-up scan. The recommendation was
based on additional observations that intra-observer variability in CT measurement may be
smaller than inter-observer variability.
Some studies investigated radiologist-dependent factors that may affect the
variability. Revel et al. and Prasad et al. identified that different preferences on guideline
may aggravate the inter-observer variability in CT measurement (Prasad et al., 2002; Revel
et al., 2004). In a study by Gietema et al., the researchers investigated the association
between different measurement techniques and aggravated inter-observer variability in
measurement. Another study by Dinkel et al. investigated and demonstrated the similar
association between the use of different measurement techniques and improved or
aggravated intra-rater correlations coefficients.
Additionally, multiple studies have identified that greater reader experience
resulted in a higher consistency of measurements (Gilles, 2011; A. McErlean et al., 2013).
In particular, the study by McErlean et al. reported the varying level of intra- and interobserver variability among radiology fellow group (defined as having up to one year of
experience), junior radiologist group (defined as having less than 7 years of experience)
and senior radiologist group (defined as having less than 7 years of experience). In general,
the experience level was inversely proportional to the level of both intra- and inter-observer
variability by the radiologist groups when evaluated by intraclass correlation coefficient.
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Use of Statistical Correlation Coefficient in Medical Research

As illustrated in the previous chapter, predominant methods for evaluation of the
inter-observer variability in radiologic measurements typically incorporated measures
based on statistical correlation coefficient. Among several measures based on statistical
correlation coefficient, Intraclass Correlation Coefficient (ICC) is particularly a widely
used reliability measure comparing the variability of different ratings by the same raters to
the total variation across all ratings and all raters. This reliability measure has been
perceived as an appropriate measure to evaluate the variability as it can be used for test–
retest, intra-rater and inter-rater reliability analyses when the rating scale is continuous or
ordinal.
Meanwhile, more researchers outside the field of radiology have been warning that
the use of statistical correlation coefficients for evaluation of inter-rater measurement
variability may be misleading in many cases. Bobak et al. demonstrated that misuse of the
ICC score under common assumption violations is likely to offer inflated estimates of
interrater reliability (C. A. Bobak, Barr, & O'Malley, 2018). Specifically, the study
suggested that ICC as a statistical measure is subject to a variety of assumptions such as
normality and stable variance, which may aggravate the inflation when violated. In the
study, two clinicians retrospectively reviewed a total of 311 audio-visual recordings of the
patient-clinician encounters and measured Observer OPTION 5 score which quantifies the
level of Shared Decision Making between clinicians and patients. The researchers
demonstrated that ICC score varies by patient-physician encounters within studies and
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across studies, which violates its basic assumptions. Moreover, good ICC score is highly
contextual; whether an ICC score is high enough should rely on the domain expertise and
intended use of the method (D. Liljequist, B. Elfving, & K. Skavberg Roaldsen, 2019).
While there are some recommendations on how the scores can be interpreted, the
recommendations may not be applicable to certain experiments situations. For example,
repeated clinical measurements may be prone to measuring equipment or successive tests
rather than humans performing the measurements.
The controversy dates back to 1970s, when several researchers in the field of
psychology observed that measurement using the correlation coefficient can seriously
mislead the entire statistical analysis if not used appropriately. Some researchers listed ICC
as one of the most commonly misused indicators of rater reliability (Bartko, 1976; P. E.
Shrout & J. L. Fleiss, 1979). In a study by Shrout et al., some examples of the misuses
included misinterpretation of relevant scores and scales, failure to select an appropriate
variation of the measure, and violation of some of its basic assumptions.

Gaps in Literature

First, it remains unclear whether the conventional statistical measures correctly
evaluate the CT measurement consistency for optimal treatment management and decision
making. As stated, definition of good ICC score is highly contextual. In the field of
radiology, there is a paucity of research investigating how high statistical correlation
coefficient scores should be to ensure mitigated clinical risk associated with the inter-
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observer variability in lesion measurement. As an example, an ICC score of 0.9 is
considered to be a very high score regardless of the field of study; however, it is unknown
whether the score can be utilized to ensure the applicability of 20-percent rules suggested
by the predominant treatment response evaluation guidelines.
Second, it remains unclear whether those correlation measures are responsive or
sufficiently sensitive to varying level of inter-observer measurement variability. When
there are groups of radiologists with relatively high and low inter-observer variability, the
measures may fail to detect the difference with unduly high scores for both groups. The
responsiveness of the score is particularly important when performing an interventional
study aiming to reduce the inter-observer variability.
Lastly, there are very few interventional studies looking at ways of reducing the
inter-observer variability in measurement among experienced radiologists. This is partly
due to previous studies concluding no significant inter-observer variability in CT
measurements. For the same reason, no clinical decision support tool was ever designed to
assist radiologist in reducing the inter-observer variability.
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CHAPTER THREE
STUDY OBJECTIVES
Study 1
Primary Objectives
•

Propose and assess a new approach that offers precision in evaluation of the interobserver variability as well as actionable thresholds on how the inter-observer
variability can be addressed in daily clinical practice

Secondary objectives
•

Assess whether the conventional methods can appropriately evaluate the interobserver measurement variability when inter-observer variabilities are substantial

Study 2
Primary Objectives
•

Assess whether a peer benchmarking tool may have an influence on reducing the
inter-observer variability among experienced radiologists

Secondary objectives
•

Investigate whether the inter-observer variability is primarily influenced by random
or systematic bias

•

Identify possible barriers contributing to the inter-observer variability
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Study 3
Primary objectives
•

Investigate whether deep learning technology can offer a tool that
supports radiologists when producing CT measurements

Secondary objectives
•

Assess if greater than 90% of automated CT measurements produced by deep
learning- based clinical decision support tool have less than 20% variation from
ground-truth measurements

•

Deep learning-based clinical decision support tool capable of suggesting
longest measurement axis
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CHAPTER FOUR
PAPER 1: “RETROSPECTIVE COMPARISON OF APPROACHES TO
EVALUATING INTER-OBSERVER VARIABILITY IN CT TUMOUR
MEASUREMENTS IN AN ACADEMIC HEALTH CENTRE”

Abstract
Background
A growing number of research studies have reported inter-observer variability in sizes of
tumors measured from computed tomography (CT) scans. It remains unclear whether the
conventional statistical measures correctly evaluate the CT measurement consistency for
optimal treatment management and decision making. We compared and evaluated the
existing measures for evaluating inter-observer variability in CT measurement of cancer
lesions.

Methods
13 board-certified radiologists repeatedly reviewed 10 CT image sets of lung lesions and
hepatic metastases selected through a randomization process. A total of 130
measurements under RECISTS 1.1 guidelines were collected for the demonstration.
Intraclass correlation coefficient (ICC), Bland-Altman plotting, and outlier counting
methods were selected for the comparison. Each selected measure was used to evaluate
three cases with observed, increased, and decreased inter-observer variability.
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Results
The ICC score yielded a weak detection when evaluating different levels of the interobserver variability among radiologists (increased: 0.912; observed: 0.962; decreased:
0.990). The outlier counting method using Bland-Altman plotting with 2 standard
deviation yielded no detection at all with its number of outliers unchanging regardless of
level of inter-observer variability. Outlier counting based on domain knowledge was
more sensitized to different levels of the inter-observer variability compared to the
conventional measures (increased: 0.756; observed: 0.923; improved: 1.000).
Visualization of pairwise Bland-Altman bias was also sensitized to the inter-observer
variability with its pattern rapidly changing in response to different levels of the interobserver variability.

Conclusions:
Conventional measures may yield weak or no detection when evaluating different levels
of the inter-observer variability among radiologists. We observed that the outlier counting
based on domain knowledge was sensitized to the inter-observer variability in CT
measurement of cancer lesions.
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Background

Clinical evaluation of cancer therapeutics is based on the assessment of change in tumor
burden, which is an important surrogate marker reflecting the therapeutic efficacy of cancer
treatments. A comprehensive evaluation of tumor burden often involves a series of
measurements of multiple tumor diameters. Measurement accuracy and consistency are
essential; a large inter-observer variability in measuring tumor size may interfere with
precise assessment of cancer treatment response when serial measurements are performed
by multiple radiologists. Some studies suggest there are radiologist-dependent factors (e.g.
preferred guideline, measurement technique, years of clinical experience) that may
contribute variability in the anatomic measurements.(Jiang, Zhou, Sun, & Wang, 2017; A.
McErlean et al., 2013; Oxnard et al., 2011; Singh, Maxwell, Baker, Nicholas, & Lo, 2011;
Thiesse et al., 1997; M. Woo, S. L. Lowe, A. M. Devane, & R. W. Gimbel, 2020) A
potentially heightened patient risk associated with the inter-observer variability may be
present when a patient’s repeat CT imaging is assigned to a radiologist different from the
radiologist who originally measured the tumor. As a result, clinical disagreement due to
the variability between the radiologists may result in an unnecessary change in treatment
management.
Predominant methods for evaluation of the inter-observer variability in radiologic
measurements typically include measures based on statistical correlation coefficient and
Bland-Altman plot.(Chung et al., 2016; Cornelis et al., 2017; Dinkel et al., 2013; Katherine
M. Krajewski et al., 2014; A. McErlean et al., 2013; Nishino, Jackman, et al., 2010; Tyng
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et al., 2009; Wormanns, Diederich, Lentschig, Winter, & Heindel, 2000; B. Zhao et al.,
2009) While these measures serve as useful assessment instruments in many other
fields,(Hemphill, 2003; Mukaka, 2012; P. E. Shrout & J. L. Fleiss, 1979; Wolak, Fairbairn,
& Paulsen, 2012) their use in evaluating the variability in radiologic measurements has not
been adequately explored. There is a paucity of research investigating either the absolute
or comparative effectiveness of these measures in evaluating inter-observer measurement
variability among radiologists. Despite multiple statistical studies containing an explicit
warning against the use of correlation-based measures and visualization in some
cases,(Carly A Bobak, Barr, & O’Malley, 2018; David Liljequist, Britt Elfving, & Kirsti
Skavberg Roaldsen, 2019; Ludbrook, 2010; Ponzoni & James, 1978; Shoukri & Donner,
2001; Weinberg & Patel, 1981) it remains unclear whether the measures are sufficiently
responsive to appropriately evaluate the inter-observer variability. Consequently, it is also
not known whether these measures can be utilized for interventional studies aiming to
reduce inter-observer variability in measurement.(MinJae Woo et al., 2020) Previous
studies on inter-observer variability in radiologic measurement have reported correlation
coefficient scores ranging from 0.860 to 0.999.(Chung et al., 2016; Katherine M. Krajewski
et al., 2014; A. McErlean et al., 2013; Nishino, Jackman, et al., 2010; Tyng et al., 2009;
Wormanns et al., 2000; B. Zhao et al., 2009) From a radiologist’s perspective, these
numbers offer little clinical insight on level of the inter-observer variability other than the
fact that the scores are very high. The question of how high score is small inter-observer
variability is open for further investigation.
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In this paper using cases with different levels of inter-observer measurement
variability, we compare sensitivity and clinical usefulness of different evaluation measures
for inter-observer variability in CT lesion measurements. Additionally, cases were assessed
using these measures to offer a better clinical insight for the question of how high the scores
should be to achieve clinically acceptable measurement variability in daily clinical
practice.

Methods

Our demonstration is based on three cases with increased, observed, and decreased interobserver measurement variability that were generated from real clinically observed data.
Descriptions of how data were generated for each case are detailed below. The observed
dataset was acquired from a single-site, double-blinded, observational study, conducted in
the Department of Radiology, Prisma Health System, located within the Southeast United
States. The study was conducted between July 2017 to December 2017. The Department
of Radiology operates in an academic health center but does not train radiology residents.

Collecting observed data
Data were collected from 13 board-certified radiologists who regularly read CT
examinations of lung lesions and hepatic metastasis. Each of the 5 lung lesions and 5
hepatic metastases samples were randomly selected from the Picture Archiving and
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Communication System (PACS) following two primary criteria: a) whether the lesions are
measurable under the Response Evaluation Criteria in Solid Tumors (RECIST) 1.1
guideline, and b) whether the lesions are commonly encountered in clinical practice. See
Supplemental Material 4.1, which are the selected images. These CT images contained
normal anatomy cephalad and caudal to the lesion of interest. Each CT image set did not
contain any recommendations regarding measurement. The 13 radiologists independently
reviewed the same 10 CT image sets, which resulted in a total of 130 measurements
(13×10). Individual radiologists adjusted the window level according to their preferences,
as they would in their clinical practice. According to RECIST 1.1 criteria, only the longest
CT axis of a tumor image and its corresponding measurement were collected.

Creating cases with different levels of inter-observer variability
The original observed data were used to generate cases with increased, observed, and
decreased inter-observer measurement variability. The extent of variability classified as
increased, observed, or decreased does not indicate the absolute level of measurement
variability; the classifications were used to indicate different cases with relatively high or
relatively low inter-observer variability. The original observed data served as the data
representing the case with observed inter-observer measurement variability.
We generated data representing the case with increased inter-observer variability
by moving each measurement in the observed data away from the nearest peer
measurements. Specifically, we inflated the inter-observer variability by increasing the
deviation of each measurement from the corresponding median by 40% to create a case
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with evidently unacceptable measurement variability. Similarly, the deviation of each
measurement from the corresponding median was decreased by 40% in the case with
decreased inter-observer variability, Figure 4.1. The percent differences between each
measurement and the corresponding median were visualized using scatter plots for all CT
image sets, Figure 4.2. The raw data for each case can be found in Supplemental Material
4.2.

Description of Selected Measures for Comparison
We selected evaluation measures based on Intraclass correlation coefficient (ICC) and
Bland-Altman plot, which are commonly used for the assessment of intra- and interobserver variability in CT measurement.(Chung et al., 2016; Cornelis et al., 2017; Dinkel
et al., 2013; Katherine M. Krajewski et al., 2014; A. McErlean et al., 2013; Nishino,
Jackman, et al., 2010; Tyng et al., 2009; Wormanns et al., 2000; B. Zhao et al., 2009) While
Bland-Altman plot is graphical method rather than statistical measure, some well-respected
studies utilized the plotting for tracking a number of outlier measurement differences
outside the 2SD upper and lower Limit of Agreement (LOA).(Faria, Faria, Cardeal, & Ito,
2014; Katherine M. Krajewski et al., 2014; A. McErlean et al., 2013) Accordingly, we
quantified Bland-Altman plots using a number of data points exceeding the upper and
lower LOA. The plotting compares two radiologists at a time; for each case, we performed
a pairwise Bland-Altman analysis for all possible pairs within a group of radiologists and
counted the total number of outliers from all pairs, Supplemental Material 4.3. If the
number of outliers from Bland-Altman plot is sensitized to the different levels of inter-
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observer variability, more outliers (i.e. higher proportion of outlier measurement
differences) would be observed in the case with increased inter-observer variability.
In the clinical context, this pairwise approach explores how safely a patient can be
transferred from one radiologist to another within a group of radiologists. If two
radiologists reviewed the same set of CT cases but suggested measurements largely
different from each other, there may be concerns associated with the patient transfer
between the radiologists. Similarly, if two radiologists reviewed the same set of CT cases
and suggested measurements similar to each other, the concerns associated with the patient
transfer may be marginal. Having more pairs with fewer outlier measurement differences
may imply less concern for inter-observer variability when a patient is reviewed by
multiple radiologists.

Statistical Analysis
We compared three evaluation measures for the comparison: (1) ICC, (2) Bland-Altman
plot with 2SD LOA, (3) Bland-Altman plot with 20% fixed LOA. As for estimations of
ICC scores, a two-way random-effects model that characterizes absolute agreement by
incorporating both lesion-wise effect (target effect) and radiologist-wise effect (rater
effect) was applied for both simulated and observed data.(Gutin et al., 1996; Koo & Li,
2016; A. McErlean et al., 2013; Mukaka, 2012) The ICC scores were estimated based on
all 130 measurements for each case (increased, observed, decreased).
While Bland-Altman plot allows data to be analyzed both as unit differences plot
and as percentage differences plot,(Giavarina, 2015) we used percent difference plot as
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suggested by previous studies in the literature.(Gutin et al., 1996; Katherine M. Krajewski
et al., 2014; A. McErlean et al., 2013) Bland-Altman plot with 2SD LOA was quantified
into score value by calculating proportion of data points within the upper and lower LOA.
Bland-Altman plot with 20% fixed limits was also quantified into score value to
compare with ICC and standard Bland-Altman plot with 2SD limits. There have been
several clinical studies using Bland-Altman plot with fixed limits of agreement evidenced
by relevant domain knowledge.(Bogui et al., 2013; Vent-Schmidt et al., 2015) This
essentially aligns with other studies that utilize clinical domain knowledge to define
outliers.(Bergamin, Anderson, & Kardon, 2004; Montalbano et al., 2019; Motulsky &
Brown, 2006; Schold et al., 2017) We fixed the maximum acceptable LOA to assess the
measurement interchangeability between radiologists at 20% evidenced by clinical
guidelines. The predominant guideline for cancer treatment response evaluation, RECIST
1.1, heavily depends on percent difference in lesion diameter with a progression defined as
a 20% increase in the sum of longest diameters.(Nishino, Jagannathan, Ramaiya, & Van
den Abbeele, 2010; Lawrence H. Schwartz et al., 2016) The absolute inter-radiologist
difference already exceeding 20% in CT measurements may interfere with the application
of the 20% criterion from the guideline when a patient is reviewed by different radiologists.
Thus, the 20% measurement difference was utilized as the fixed LOA for the Bland-Altman
plot. In the context of radiologic measurement, this means that outlier measurement
difference is explicitly defined as measurement difference exceeding 20% when a pair of
radiologists reviewing the same image.
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Bland-Altman plot also allows identification of any systematic difference (mean
difference in measurements) between two observers. For each case of inter-observer
variability, the mean difference in measurements was calculated for all possible pairs
(n=78) and visualized in a heat map, Figure 4.3.

Results

Characteristics of CT image sets included in the study
Each CT image set included in the study consisted of multiple CT slices with an average
of 7.6 images, Table 4.1. The minimum and maximum size of the hepatic metastases
ranged between 1.68 cm to 2.21 cm and 5.32 cm to 6.72 cm, respectively. The minimum
and maximum size of lung lesions ranged between 1.27 cm to 1.68 cm and 3.69 cm to 5.02
cm, respectively. In the observed data, the largest lesion-wise percent difference in
measurements was realized in Hepatic Metastasis 5 with 33.1% difference between the
minimum and maximum measurements. The smallest lesion-wise percent difference in
measurements was realized in Lung Lesion 2 with 14.5% difference between the minimum
and maximum measurements.

Characteristics of cases with different levels of inter-observer variability
The graph visualization of the data from each case suggested varying levels of interobserver variability, Figure 4.2. The visualization of the original observed data suggested
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a substantial inter-observer variability with 31 (23.8%) measurements outside the light blue
area representing plus or minus 10% interval from the average measurement value for each
case. Additionally, a lesion-wise effect on inter-observer variability was observed with
relatively high measurement variation in some CT image sets. The visualization of the case
of decreased inter-observer variability illustrated a small number of measurements outside
the threshold with 3 (2.3%) measurements locating outside the plus or minus 10% interval.
With the decrease in the deviations of each measurement from the corresponding median,
all measurements moved towards average and closer together as intended for
demonstration. On the other hand, there was a relatively large number of measurements
outside the threshold in the case of increased inter-observer variability with 50 (38.5%)
measurements locating outside the plus or minus 10% interval. Also, it was observed that
all measurements were not only shifted away from median, but also moved further away
from each other as intended.

Visualization of Bland-Altman Analysis
The heat map visualization of average percent measurement difference (fixed bias) for all
pairs of radiologists suggested varying levels of the difference across all pairs, Figure 4.3.
Some pairs of radiologists achieved a lower average percent difference than others. In the
heat map of the original observed data, the smallest systematic difference in measurement
was observed in the pair of Radiologist 11 and Radiologist 13; they maintained an average
of 0.03% difference in their measurements when reviewing the same set of CT images. The
largest systematic measurement difference was observed in the pair of Radiologist 1 and
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Radiologist 6. The systematic difference in their measurements was 13.6% when reviewing
the same set of CT images. It was observed that some radiologists attributed more to interobserver variability than others; Radiologist 1 and 10 generally overestimate lesion size
compared to others while Radiologist 2 and 6 generally underestimated lesion size
compared to others.
The heat map visualization from the case of increased inter-observer variability
showed the increased systematic measurement differences between any two radiologists
compared to other cases. Similarly, the heat map visualization from the case of decreased
inter-observer variability showed the decreased systematic measurement differences
compared to other cases. Overall, the cases with relatively high inter-observer variability
tend to present the increased systematic measurement differences between any two
radiologists as well as more pairs of radiologists with a systematic measurement difference
close to 20% when reviewing the same CT image sets.

Comparison of the selected measures
The original observed data achieved the ICC score of 0.962. The ICC scores in the cases
of increased and decreased inter-observer variability were 0.990 and 0.912, respectively.
The percent increase in the deviation of each measurement from the corresponding median
has a perfect linear relationship with the ICC score (R-squared = 1.00), Figure 4.4.
However, the magnitude of association was extremely low; 10 percent increase in the
deviation was associated with 0.01 decrease in the ICC score. As a result, the graph
representing a relationship between a percent increase in the deviation and the
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corresponding ICC score presented a virtually flat slope, which implies that the score is
extremely insensitive to the changes in deviations.
The original observed data achieved the standard Bland-Altman score of 0.937,
which indicates 93.7% of data points within lower and upper LOA along with 6.3% outlier
data points. The score based on standard Bland-Altman presented flat slope with its score
unchanging regardless of level of inter-observer variability (standard Bland-Altman
score=0.937).
The presented Bland-Altman score with fixed limits was more responsive to the
change in case than other measures. In the case with decreased inter-observer variability,
all pairs were identified to have a percent difference less than 20% when reviewing the
same CT image sets (fixed-limit Bland-Altman score=1.0). The original observed data
suggested Bland-Altman score with fixed limits of 0.923 with 92.3% of all possible
pairwise measurements having a percent difference less than 20%. In the case with
increased inter-observer variability, 75.6% of measurements were identified to have a
percent difference less than 20% when reviewing the same CT image sets. The BlandAltman score with fixed limits changed by 0.167 (0.756 to 0.923) between increased case
and observed data, and 0.077 (0.923 to 1.000) between observed data and increased case,
Figure 4.4.

Implications for patient care
The proposed Bland-Altman score with 20% fixed limits offers interpretable
insights on applicability of the 20% rule from the clinical guidelines when a patient must
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be assigned to different radiologists. The score suggests a patient’s chance of being
assigned to a radiologist whose measurements are comparable (i.e., smaller than 20%
measurement difference) to the previous radiologist. When a patient is assigned to different
radiologist other than the radiologist who initially review the case, this creates a pair of
radiologists who reviewed the same patient in the course of cancer treatment. The score is
designed to be sensitize to the number of pairs of radiologists who generally produce
measurements different from each other. Thus, a larger number of the concerning pairs
with measurement difference larger than 20% would decrease the proposed Bland-Altman
score with 20% fixed limits. As for the clinical implications, the lower Bland-Altman score
with the fixed limits indicates a larger number of concerning pairs of radiologists who may
review the same patients over time. Another implication of the approach offers a radiologist
assignment mapping based on the dissimilarity between any pair of radiologists, Table 4.2.
The mapping enables radiologists to be assigned the next-best peer radiologist with whom
they achieved the minimal measurement difference based on the observed data.

Discussion

The importance of consistent measurement of cancer lesions in CT scans has been well
documented.(Nishino, Jackman, et al., 2010; Nishino, Jagannathan, et al., 2010; Lawrence
H. Schwartz et al., 2016) We have performed an extensive simulation study using
conventional evaluation measures and different cases with varying levels of inter-observer
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variability. Our study investigated precision of those measures and found that some
measures are not sensitive enough to detect the difference between cases with clinically
desirable and clinically unacceptable inter-observer variability in radiologic measurement.
The previous studies by McErlean et al and Zhao et al utilized statistical correlation
coefficients and standard Bland-Altman plot as primary measures and concluded that serial
CT measurements can be safely performed by different radiologists.(A. McErlean et al.,
2013; B. Zhao et al., 2009) Our study indicated that the correlation-based measures may
fail to serve as a true indicator of inter-observer variability. When the observed data were
analyzed, the radiologists in our study achieved a high ICC score comparable to previous
studies.(Dinkel et al., 2013; A. McErlean et al., 2013) However, as demonstrated above, a
high ICC score does not always guarantee low inter-observer variability in the context of
radiologic measurement. Our analysis suggests that the statistical correlation-based
measures may yield high scores regardless of level of the inter-observer variability among
radiologists. Therefore, a group of radiologists who achieved a high ICC score within the
group could fail to maintain clinically reasonable measurement consistency. For instance,
an ICC score of 0.9 achieved by a group of readers is often considered to be excellent in
many other fields.(Gellhorn & Carlson, 2013; Lawrence H. Schwartz et al., 2016)
However, in the case of cancer treatment response evaluation, the ICC score of 0.9 may
raise serious patient safety concerns with radiologists always having at least 10% average
percent difference in measurement to each other when reviewing the same CT image sets.
In the presented case with increased inter-observer variability, the ICC score of 0.91 was
still not high enough to achieve clinically acceptable inter-observer variability in CT
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measurement, as affirmed by the participating radiologists, Supplemental Material 4.2.
Despite the unrealistically high increase in the variability observed in the case with
increased inter-observer variability, the ICC score failed to provide an adequate warning.
Another measure, outlier counts from standard Bland-Altman plotting with 2SD
upper and lower LOA, presented no response to the varying levels of inter-observer
variability in CT measurements. It was observed that its upper and lower limits increase
proportionally to measurement variabilities. Our analysis suggested no evidence to support
its use for the assessment of CT measurement variability or outlier detection.
While the standard Bland-Altman and ICC scores changed little across the different
cases, the presented Bland-Altman score with 20% fixed limits rapidly changed between
cases of increased, observed and decreased inter-observer variability. The presented score
is also intuitive to interpret because of its self-descriptive nature; the decrease in the score
from 0.923 to 0.756 means that the percentage of pairwise measurements having less than
20% difference has decreased from 92.3% to 75.6%. As documented, the predominant
guideline for cancer treatment response evaluation defines a diameter increase of 20% as
the cutoff for progression of cancer. If multiple pairs of measurements have 20% or higher
measurement difference over the same CT image sets, this may interfere with the
application of the 20% criterion from the guideline when a patient is reviewed by different
radiologists. The Bland-Altman score with fixed limits demonstrated a potential to detect
a decrease in the number of pairs having less than 20% measurement difference when
reviewing the same image sets, which may better facilitate the application of guideline.
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The Bland-Altman heat map of pairwise systematic discrepancy offered some
useful insight on how the inter-observer variability can be addressed in interventional
studies. The visualization identified radiologists who largely under- or over-measure
compared to their peers, which can be a potential target for intervention to reduce the
variability. Risk associated with inter-observer variability is realized when a patient is
referred from one radiologist to another or reviewed by different radiologists. The pairwise
approach to visualize systematic discrepancy may also be useful in addressing the risk by
identifying pair of radiologists whose measurements typically differ greatly from each
other.
A potential limitation of the study may result from the image selection process.
Although the images were randomly selected from the health system PACS, the application
of the selection criteria was performed by one senior radiologist. A selection criterion was
whether or not images are commonly encountered in daily clinical practice, which may
have introduced a bias in the image selection. Another limitation is that the measurements
were collected under a highly controlled environment where the radiologists were rarely
interrupted throughout the data collection. It is commonly believed that in real-world
clinical practice, one's actual performance may be negatively affected by a heavy workload
or various types of interruptions. Lastly, the suggested measure to evaluate dissimilarity
between two radiologists is overly simple. There is a need for additional research to
understand how the measurement similarity between two radiologists can be better
measured in real-world clinical settings.

31

Conclusion

Conventional measures may yield weak or no detection when evaluating different levels of
the inter-observer variability among radiologists. We observed that the outlier counting
based on domain knowledge was sensitized to the inter-observer variability in CT
measurement of cancer lesions. Our study demonstrated that, under certain circumstances,
the use of standard statistical correlation coefficients may be misleading and result in a
sense of false security related to the consistency of measurement. A visualization based on
pairwise approach to identify systematic discrepancy may serve as a useful and practical
tool for future efforts to reduce the inter-observer variability in radiologic measurement.
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Figures
Figure 4.1. Example of increased and decrease inter-observer variability from observed
data. To generate a case with increased inter-observer variability, the difference between
each measurement and the median value was increased by 40% (right). The difference
between each measurement and the median value was decreased by 40% in the case with
decreased inter-observer variability (left).
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Figure 4.2. Visualization of measurement distribution for each case. Each vertical line in
the graphs represent different CT case and each point represent percent difference
between a measurement and the corresponding median value. The light blue area
represents plus and minus 10% interval from the median value.
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Figure 4.3. Visualization of pairwise bias from Bland-Altman analysis. The systematic
discrepancy (bias) was calculated using average percent differences and presented in
decimal format. Darker red colors represent larger percent measurement differences. The
positive values indicate that the radiologist on y-axis over-estimated compared to the
radiologist on x-axis. The negative values indicate that the radiologist on y-axis underestimated compared to the radiologist on x-axis.

Case - Observed Inter-observer Variability

Case - Decreased Inter-observer Variability

Case - Increased Inter-observer Variability
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Figure 4.4. Responsiveness comparison of Intraclass Correlation Coefficient and BlandAltman outlier scores. Scaling factor d represents percent increase in the deviation of
each measurement from the corresponding median. Horizontal axis corresponds to
scaling factor d used to decrease or increase the inter-observer variability. Vertical axis
represents ICC and Bland-Altman scores. Vertical dotted lines in red represent different
datasets. ICC score – Intraclass Correlation Coefficient. 2SD – 2 Standard Deviation.
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Figure 4.5. Standard Bland-Altman plotting for the selected pairs. The upper and lower
Limit of Agreement (LOA) were calculated using 2 standard deviations. The dotted and
solid lines represent LOA and mean difference, respectively. Different colors represent
different radiologist pairs. While there were a total 78 possible pairs, the plotting
included 6 selected pairs for visualization purposes. The total number of outliers was
unchanging across the different cases, regardless of the number of pairs in the plotting,

Case - Observed Inter-observer Variability

Case - Decreased Inter-observer Variability

Case - Increased Inter-observer Variability
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Tables

Table 4.1. Descriptive statistics for the original observed data
CT image sets
Hepatic Metastasis 1
Hepatic Metastasis 2
Hepatic Metastasis 3
Hepatic Metastasis 4
Hepatic Metastasis 5
Lung Lesion 1
Lung Lesion 2
Lung Lesion 3
Lung Lesion 4
Lung Lesion 5

Number of
image slices
9
5
5
13
6
8
10
6
10
4

Median Measurements
(S.D.)
4.46 (0.38)
2.68 (0.22)
1.91 (0.18)
6.14 (0.48)
2.68 (0.29)
3.46 (0.24)
4.18 (0.23)
2.00 (0.17)
4.29 (0.36)
1.56 (0.11)

Range
(3.81–5.19)
(2.31–3.03)
(1.68–2.21)
(5.32–6.72)
(2.24–3.13)
(3.10–3.86)
(3.90–4.51)
(1.71–2.37)
(3.69–5.02)
(1.27–1.68)

Min-Max Percent
Difference
30.7%
27.0%
27.2%
23.3%
33.1%
21.8%
14.5%
32.4%
30.5%
27.8%

Note: Average measurement and range are in centimeters (cm). S.D. denotes standard deviation. Min denotes minimum
measurement for each lesion. Max denotes maximum measurement for each lesion. Percent difference between minimum and
maximum values was calculated using the following formula: difference(min, max) / average(min, max). Range consists of
(minimum observed value – maximum observed value).

42

Table 4.2. Prearranged radiologist assignment mapping based on the dissimilarity scores.
Radiologist
1
2
3
4
5
6
7
8
9
10
11
12
13

Order of radiologists with ascending inter-radiologist variability
12 → 8 → 10 → 5 → 13 → 2 → 9 → 11 → 4 → 7 → 3 → 6
13 → 8 → 5 → 7 → 12 → 11 → 6 → 3 → 4 → 1 → 9 → 10
4 → 2 → 8 → 7 → 11 → 13 → 12 → 5 → 1 → 6 → 10 → 9
3 → 8 → 13 → 2 → 10 → 11 → 1 → 5 → 6 → 12 → 7 → 9
12 → 6 → 9 → 1 → 2 → 13 → 8 → 11 → 4 → 7 → 3 → 10
5 → 7 → 2 → 9 → 12 → 11 → 8 → 13 → 4 → 1 → 3 → 10
6 → 2 → 11 → 3 → 13 → 12 → 8 → 5 → 4 → 1 → 9 → 10
12 → 1 → 2 → 13 → 5 → 9 → 4 → 3 → 11 → 10 → 7 → 6
5 → 8 → 12 → 6 → 1 → 13 → 2 → 10 → 4 → 7 → 11 → 3
1 → 13 → 4 → 8 → 12 → 11 → 5 → 9 → 2 → 3 → 7 → 6
13 → 2 → 7 → 5 → 3 → 4 → 1 → 8 → 6 → 12 → 10 → 9
1 → 5 → 8 → 2 → 9 → 13 → 7 → 6 → 11 → 10 → 4 → 3
2 → 11 → 8 → 5 → 1 → 12 → 4 → 10 → 7 → 9 → 6 → 3

Note: All numbers denote radiologist number. Arrows point towards the next preferred
radiologist whose measurements are most comparable to the radiologist in the first column
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Supplemental Material

Supplemental Material 4.1
Examples of measurement for all CT image sets used in this study.
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Supplemental Material 4.2.
To generate new data M’ik for the i-th radiologist measurement of the k-th case
representing each case, we used the following formula with a function of a scaling factor
d on a percent scale:
%%%%
%%%%
𝑀′!" = 𝑀
" + (1 + 𝑑/100)( 𝑀!" − 𝑀" ).

%%%%
Here, 𝑀!" is the observed reading of the i-th radiologist i for the k-th case, and 𝑀
" is the
median of measurements for the k-th case over all 13 radiologists. Specifically, we
adjusted the inter-observer variability by assigning different values of the factor d to the
%%%%
deviation 𝑀!" − 𝑀
" for each radiologist. We assigned d = 40, 0, and -40 so that the
generated new M’ik measurement data represent those with increased, observed, and
decreased inter-observer variability, respectively; the deviation of each radiologist-level
measurement from the case-specific mean was increased, unchanged, or decreased by
d%.
Case with Increased Inter-observer Variability
Set

Radiologist
1

2

3

4

5

6

7

8

9

10

11

12

13

1

5.14

4.20

3.52

3.71

4.46

4.06

4.65

4.19

4.62

4.23

4.46

5.45

4.79

2

2.87

2.47

2.79

2.91

2.23

2.14

2.52

3.07

2.80

3.15

2.35

2.68

2.55

3

2.23

1.84

1.98

1.91

1.88

1.64

1.67

2.38

2.38

2.12

1.70

1.98

1.74

4

6.86

5.36

6.14

6.51

6.51

4.97

4.90

5.63

6.06

6.73

6.66

6.58

5.75

5

3.14

2.27

2.12

2.57

2.86

2.46

2.32

3.30

2.86

3.07

2.57

3.37

2.68

6

3.46

3.44

4.13

3.62

3.40

3.34

4.10

3.61

3.06

3.36

3.99

3.18

3.61

7

4.40

3.95

4.63

4.01

3.79

3.86

4.63

4.18

3.91

4.21

4.64

3.81

4.28

8

2.03

2.48

2.06

1.88

2.03

1.56

1.89

1.92

1.56

2.00

2.07

2.00

2.07

9

4.15

4.29

4.96

5.19

4.15

4.01

4.22

4.36

3.61

5.47

4.57

4.26

4.59

10

1.70

1.47

1.12

1.46

1.35

1.60

1.60

1.50

1.56

1.68

1.50

1.58

1.68
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Case with Observed Inter-observer Variability
Set

Radiologist
1

2

3

4

5

6

7

8

9

10

11

12

13

1

4.95

4.28

3.79

3.93

4.46

4.18

4.60

4.27

4.58

4.30

4.46

5.17

4.70

2

2.82

2.53

2.76

2.85

2.36

2.30

2.57

2.96

2.77

3.02

2.45

2.68

2.59

3

2.14

1.86

1.96

1.91

1.89

1.72

1.74

2.25

2.25

2.06

1.76

1.96

1.79

4

6.65

5.58

6.14

6.40

6.40

5.30

5.25

5.77

6.08

6.56

6.51

6.45

5.86

5

3.01

2.39

2.28

2.60

2.81

2.52

2.42

3.12

2.81

2.96

2.60

3.17

2.68

6

3.46

3.45

3.94

3.58

3.42

3.38

3.92

3.57

3.18

3.39

3.84

3.26

3.57

7

4.34

4.02

4.50

4.06

3.90

3.95

4.50

4.18

3.99

4.20

4.51

3.92

4.25

8

2.02

2.34

2.04

1.91

2.02

1.68

1.92

1.94

1.68

2.00

2.05

2.00

2.05

9

4.19

4.29

4.77

4.93

4.19

4.09

4.24

4.34

3.80

5.13

4.49

4.27

4.50

10

1.66

1.50

1.25

1.49

1.41

1.59

1.59

1.52

1.56

1.65

1.52

1.58

1.65

Case with Decreased Inter-observer Variability
Set

Radiologist
1

2

3

4

5

6

7

8

9

10

11

12

13

1

4.75

4.35

4.05

4.14

4.46

4.29

4.54

4.34

4.53

4.36

4.46

4.88

4.60

2

2.76

2.59

2.72

2.78

2.48

2.45

2.61

2.84

2.73

2.88

2.54

2.68

2.62

3

2.04

1.88

1.94

1.91

1.89

1.79

1.80

2.11

2.11

2.00

1.82

1.94

1.83

4

6.45

5.81

6.14

6.30

6.30

5.64

5.61

5.92

6.11

6.40

6.37

6.33

5.98

5

2.88

2.51

2.44

2.63

2.76

2.58

2.52

2.94

2.76

2.85

2.63

2.97

2.68

6

3.46

3.45

3.74

3.53

3.43

3.41

3.73

3.52

3.29

3.41

3.68

3.34

3.52

7

4.27

4.08

4.37

4.11

4.01

4.04

4.37

4.18

4.06

4.19

4.38

4.02

4.22

8

2.02

2.21

2.03

1.95

2.02

1.81

1.96

1.97

1.81

2.00

2.03

2.00

2.03

9

4.23

4.29

4.58

4.68

4.23

4.17

4.26

4.32

4.00

4.80

4.41

4.28

4.42

10

1.62

1.52

1.37

1.51

1.47

1.57

1.57

1.53

1.56

1.61

1.53

1.57

1.61
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Supplemental Material 4.3.
Average percent systematic difference using pairwise approach
The pairwise average percent systematic difference δ!# was calculated for Bland-Altman
analysis. The measure is based on the average difference in measurement between any
pair of the i-th and j-th radiologists for the k-th cases as follows:
δ!# =

$ 𝑀 −𝑀
2
!"
#"
1
𝐾
"%& 𝑀!" + 𝑀#"

Here, K is the number of cases (in our study K = 10), and 𝑀!" is a measurement value of
the i-th radiologist for the k-th case.

Bland-Altman outlier scores with standard and fixed-limit
The standard Bland-Altman outlier scores Υ'() is reliant on the percentage of pairwise
measurement difference less than 2 standard deviations. Similarly, the Bland-Altman
scores Υ'*% with 20% fixed limit is reliant on the percentage of pairwise measurement
difference less than 20% and calculated as follows:

Υ',- =

.
.
(𝑁 − 2)!
6 𝑀!" − 𝑀#" 6
1 1 15
< 2𝑆𝐷 :
𝑁!
𝑀!" + 𝑀#"
!%&
#%&

Υ'*% =

.
.
(𝑁 − 2)!
6 𝑀!" − 𝑀#" 6
1 1 15
< 0.2 :
𝑁!
𝑀!" + 𝑀#"
!%&
#%&
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Here, 1( A) is an indicator function whose value is 1 if A is true and 0 otherwise. N
represents the number of radiologists. The fixed-limit Bland-Altman outlier scores were
based on the percentage of pairs where a pair of radiologists reviewed the same CT image
set and resulted in measurements that differ by less than 20%.
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CHAPTER FIVE
PAPER 2: “INTERVENTION TO REDUCE INTER-OBSERVER VARIABILITY IN
CT MEASUREMENT OF CANCER LESIONS AMONG EXPERIENCED
RADIOLOGISTS”

Abstract
Purpose
While a growing number of research studies have reported the inter-observer variability
in computed tomographic (CT) measurements, there are very few interventional studies
performed. We aimed to assess whether a peer benchmarking decision tool may have an
influence on reducing inter-observer variability in CT measurements and identify
possible barriers to the intervention.

Materials and Methods
In this retrospective study, 13 board-certified radiologists repeatedly reviewed 10 CT
image sets of lung lesions and hepatic metastases during three non-contiguous time
periods (T1, T2, T3). Each pre-selected case contained normal anatomy cephalad and
caudal to the lesion of interest. Lesion size measurement under RECISTS 1.1 guidelines,
choice of CT slice, and time spent on measurement were captured. Prior to their final
measurements, the participants were exposed to the intervention designed to reduce the
number of measurements deviating from the median. Mixed-effect logistic regression
was used to identify radiologist-dependent factors associated with the variability.
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Results
The percent of deviating measurements during T1 and T2 were 20.0% and 23.1%,
respectively. There was no statistically significant change in the number of deviating
measurements upon the presentation of the intervention despite the decrease in percent
from 23.1% to 17.7%. The identified barriers to the intervention include clinical
disagreements among radiologists. Specifically, the inter-observer variability was
associated with the controversy over the choice of CT image slice (p=0.045) and
selection of start-point, axis, and end-point (p=0.011).

Conclusion
Clinical disagreements rather than random errors were the basis of inter-observer
variability in CT measurement among experienced radiologists. Future interventions
could aim to resolve the disagreement in an interactive approach.
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Introduction

Treatment response evaluation of cancer therapeutics is based on the longitudinal
tracking of tumor burden changes, which provides an important surrogate marker for
monitoring efficacy of cancer treatments. The tumor burden in oncology is often assessed
by measuring the size of multiple target lesions and tracking the sum of the
measurements. Despite technological advancements, the current predominant guideline
for evaluation of the treatment response, the Response Evaluation Criteria in Solid
Tumors 1.1 (RECIST 1.1), recommends radiologists manually measure the lesion sizes
according to the suggested criteria (Krajewski, Nishino, Ramaiya, & Choueiri, 2015; L.
H. Schwartz et al., 2016). Inconsistency in measurements may increase risk for
suboptimal interpretation of treatment response. While the accuracy and consistency in
the evaluation of treatment response are essential for reliable treatment management, a
growing number of research studies have reported that the tumor size measurements
using computed tomography (CT) scans are subjected to inter-observer variability
(Erasmus et al., 2003; Gietema et al., 2006; Hopper et al., 1996; Jiang et al., 2017; A.
McErlean et al., 2013; Oxnard et al., 2011; Posso, Puig, Quintana, Sola-Roca, & Bonfill,
2016; Singh, Pinsky, et al., 2011; Skougaard et al., 2012; Suzuki et al., 2010; Vos et al.,
2003; Wang et al., 2008; B. Zhao et al., 2009). Some studies have investigated
radiologist-dependent factors (e.g. preferred guideline, clinical experience, measurement
techniques) that may aggravate inter-observer variability in the measurements (Jiang et
al., 2017; A. McErlean et al., 2013; Oxnard et al., 2011; Singh, Maxwell, et al., 2011; B.
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Zhao et al., 2005). There is currently no interventional study looking at ways of reducing
the inter-observer variability in unidirectional measurement of solid tumor among
experienced radiologists. It is also unknown whether the inter-observer variability is
primarily influenced by random or systematic bias.
In this pre-post study, we seek to reduce inter-observer variability in anatomic
measurement of lung lesions and hepatic metastases identified through CT examinations
housed in a picture archiving and communication system (PACS). We will develop a peer
benchmarking intervention tool tailored to each CT measurement, aimed at reducing the
inter-observer measurement variability with measurements more clustered around median
measurement. Our goal is to assess whether the peer benchmarking tool may have
influence on reducing the inter-observer variability among experienced radiologists and,
if not, identify possible barriers to the intervention.

Materials and Methods

Study design and setting
This was a single-site, double-blinded, pre-post research study conducted in a
Department of Radiology in a health system within the Southeast United States, Greenville,
South Carolina. The study was approved by the Institutional Review Board (IRB) of Prisma
Health and Clemson University. There were no changes to the methods after the study had
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commenced. Clinician participants were recruited during July 2017. The study was
conducted between August 2017 to December 2017.

Selection of participants
Study participation was limited to board-certified radiologists who read CT
examinations of lung lesions and hepatic metastases in their regular clinical practice. The
study participants were expected to be familiar with the PACS system which supports their
daily workflow. Investigators were blinded (except the research coordinator) to the identity
of clinician participants contributing measurements; research data were recorded by
participant study numbers. The participants were blinded to the specific nature of the
intervention. All participants were exposed to the same type of intervention.

Recruitment
An IRB-approved electronic email invitation from a Department of Radiology
academic leader was distributed to all radiologists and the study was announced at a
department meeting. Reminder emails were distributed as follow-up. Interested
radiologists were directed to contact the research coordinator who coordinated recruitment
efforts. Upon contact, the research coordinator explained the blinded nature of the study to
potential participants, presented the informed consent document, and coordinated data
collection with the participants.

CT case selection
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A total of 30 cases (i.e. 15 lung lesions, 15 hepatic metastases) were selected by the
physician investigator from a large pool of possible cases stored in the PACS system. The
two primary selection criteria for the selected cases were whether they were measurable
lesions under the RECIST 1.1 guidelines and if they were commonly encountered in Prisma
Health clinical practice. Each preselected case contained the entirety of the lesion of
interest as well as normal anatomy cephalad and caudal to the lesion of interest which
required participants to scroll through from the beginning. The CT image sets did not
contain any recommendations regarding from which slice to measure or how to optimally
measure the mass.
A blocked randomization process was performed to select five of 15 possible CT
image sets for each group (i.e. lung lesions, hepatic metastases) for use in the study. The
10 selected cases were subjected to anonymization procedures and placed, within the
PACS. All clinician participants reviewed the same files under the monitoring of the
research coordinator. The 10 studies were re-evaluated at 3 time-points T1, T2, and T3,
Figure 5.1.

Intervention
Our intervention was a peer benchmarking performance intervention tool presented
to research participants at T3 prior to their final CT image measurements. The peer
benchmarking tool, developed for each CT image set, included a scatter plot of
measurements and distribution of CT slice choice by peer radiologists (from T1 and T2)
and percentage differences between individual measurements and the mean of peer
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measurements, Figure 5.2. Numeric values of the mean measurement and the number of
the selected CT slices used for measurement within the CT series were not given to avoid
potential bias in the result due to excessive information. Since the given graphs did not
reveal any numeric values, the intervention limited feedback to participants to how far
below or above their measurements for the CT image set were from the mean of peer
measurements, intra-observer variability in percent, and how divergent their slice choice is
compared to others.

Study flow
The research participant data collection was conducted during three non-contiguous
time periods (i.e. T1, T2, and T3) – each separated by a minimum of 30 days. The delay
between each of the data collection points was to ensure that each research participant did
not remember specifics about any of the CT images presented to him/her in the previous
CT imaging measurement session. All participants measured 10 lesions during each
measurement session, resulting in a total of 390 lesion measurements.
Each clinician participant scheduled a total of three distinct measurement sessions
with the research coordinator. When presenting for a measurement session, the research
participants were asked to measure the long axis of the tumor as they would in ordinary
clinical practice. Additionally, time from image presentation to measurement was
recorded. When the first slice of each CT series appeared on the screen, the coordinator
started measuring time. Upon acquisition of a satisfying measurement, the radiologists
verbally called out “done”: the end-point of the time measurement. The selection of a CT
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slice for the longest axis and corresponding measurement value was collected as well as
the runtime. This process was repeated for each of the 10 CT series presented to the
research participants in T1 and T2.
During the measurement session T3, the research participants were presented with
our intervention (tailored to each CT image set), then provided the opportunity to measure
each of the 10 CT image sets. Upon collection of each measurement, research participants
were exposed to information and feedback including the mean value of peer measurements,
slice choices of majority, and a visual of sample measurements using the mean value of
peer measurements. Finally, after every T3 measurement, each research participant was
asked whether the sample measurement provided for each case was clinically acceptable
based on its start point, longest axis, and end-point. The responses to the question were
recorded in a binary format.

Statistical analysis
The level of inter-observer variability was assessed by counting the number of
measurements outside plus or minus 10% interval from the median measurement when
reviewing the same case. Specifically, we hypothesized that exposure to the intervention
would result in a decrease in the number of measurements outside the 20% threshold. The
most commonly used guideline for evaluation of treatment response, RECIST 1.1, heavily
depends on percent difference in the sum of lesion diameters with a progression defined as
a 20% increase. We assumed that, when multiple radiologists review the same case, more
measurements within the 20% threshold may mitigate the risk associated with the inter-
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observer measurement variability. A simple percent difference between the minimum and
maximum measurement values was calculated for each lesion as a supplementary indicator
of inter-observer variability. While some studies used statistical correlation coefficient as
a primary measure to assess inter-observer variability in lesion measurement (Dinkel et al.,
2013; A. McErlean et al., 2013), there have been multiple studies showing that the use of
the measures can be invalid and misleading in some cases (D. Liljequist et al., 2019; Lobbes
& Nelemans, 2013; Trevethan, 2017). Thus, measures based on statistical correlation
coefficient were avoided in this study.
Cochran’s Q test was performed to assess the presence of heterogeneity in the
number of measurements within the 20% threshold among all three sessions (T1, T2, T3).
The null hypothesis implied no significant heterogeneity across the sessions despite
exposure to the intervention prior to T3. Additionally, McNemar’s test was used to test for
a significant difference in the number of measurements within the threshold between T1
and T2.
Lastly, a regression model was adopted to determine if there is an association
between measurement deviation (i.e. measurement outside the 20% threshold) from the
median measurement for each case and radiologist-dependent factors. In particular, a
mixed-effects logistic regression model was used to address repeated nature of the
measurement data with readers and target images as crossed random effects (Ten,
Reboussin, Miller, & Kunselman, 2002). The fixed effects included one’s slice choice (i.e.,
majority’s choice or not), time spent (i.e., longer or shorter than 15 seconds), clinical
agreement on measurements from the peer-benchmark interventional tool (i.e., clinically
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acceptable or not). The analysis was performed to identify association between the listed
study variables and measurement deviation from the median measurement.

Results

Characteristics of study participants
Research participants included 13 radiologists who met the inclusion criteria and
consented to participate in the study. All participating radiologists were highly experienced
radiologists board-certified in their specialty. The Prisma Health Department of Radiology
does not operate a radiology residency program.

Characteristics of CT images included in study
Each CT image set used in the study consisted of multiple CT slices with 7.6 images
on average (range of 4 to 13 images), Table 5.1. The minimum and maximum size of the
hepatic metastases within the CT image sets fell within a range between 1.59cm to 2.29cm
and 5.32cm to 6.75cm respectively. The minimum and maximum size of the lung lesions
within the CT image sets fell within a range between 1.27cm to 1.72cm and 3.69cm to
5.02cm respectively. When comparing the difference between the minimum and maximum
measurements across all 10 CT image sets, the largest difference was realized in hepatic
metastasis 5, representing a 42% variation across research participants. The smallest
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minimum-maximum percent difference was realized in lung lesion 2, representing a 14.5%
variation across research participants.
On average, research participants consumed 24.7 seconds (per measured lesion)
from presentation of image to completion of measurement. The range was 14.3 seconds to
32.1 seconds (per case), Table 5.2.

Inter-observer variability evaluated by number of out-of-threshold measurements
A total number of within-threshold measurements observed throughout the study
period was 311 out of 390 (79.7%) measurements. During the session 1, a total of 104 out
of 130 measurements were within-threshold, Table 5.2. The number of within-threshold
measurements decreased during the session 2 from 104 to 100 out of 130 measurements.
McNemar’s test indicated no statistically significant heterogeneity in the number of withinthreshold measurements between session 1 and 2, which implies no evidence of
performance gain caused by repeated exposure to the same images over the sessions.
During the session 2, 84.6% of participants produced the same or smaller number of outof-threshold measurements when compared to the session 1.
The peer benchmarking intervention tool presented inconsistent effect on
individual radiologist. Upon presentation of the peer benchmarking intervention tool, 4
radiologists produced more out-of-threshold measurements, 2 radiologists produced the
same number of out-of-threshold measurements, and 7 radiologists produced the less
number of out-of-threshold measurements. The overall number of within-threshold
measurements increased from 100 to 107 out of 130 measurements. While the majority of
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radiologists produced more within-threshold measurements upon exposure to the
intervention, Cochran’s Q test indicates no statistically significant heterogeneity in the
number of within-threshold measurements across all sessions.

CT slice selection and measurement time
Although more than 80% of research participants selected the same CT slice within
each CT image series for measurement of maximum axis during the study, both inter- and
intra-observer variability was observed when comparing slice selection. Those selecting
CT slices that differed from their peer majority were more likely to record a deviating
measurement than those selecting the CT slice with the majority (p=0.045), Table 5.3. This
variation is visually presented in Figure 5.3. This comparison is presented for T1 and T2
only as research participants were exposed to our peer benchmarking intervention tool just
prior to T3. When comparing participant time from point of image presentation to
completion of measurement, there was no statistical difference between time and
measurement deviation, Table 5.3.

Clinical acceptability by clinician participants to our peer benchmarking intervention
tool
Our peer benchmarking intervention tool identified a measurement start point,
longest axis, and end-point for each lesion or metastasis present in the image. Our results
demonstrate there was controversy among participants on the clinical acceptability of our
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tool with irregular lesion margins. Figure 5.4 provides an example of where lesion margin
disagreement existed.
In hepatic metastasis 4, 53.8% of the participating radiologists suggested that our
peer-benchmarking measurement was clinically unacceptable while 46.2% of participants
found the measurement acceptable. Our analysis showed that there is a statistically
significant association (p=0.011) between agreement with the peer benchmarked
measurement and participant measurement deviation, Table 5.3. This suggests that
participants who found the peer benchmarked measurement unacceptable were more likely
to record deviating measurements compared to their peers. We posit that clinical
disagreements rather than random errors due to precision limitation were the basis of interobserver variability. Figure 5.5 identifies participant clinical acceptability for the peer
benchmarked measurement for the hepatic metastases and hepatic lesions used in the study.

Discussion

The importance of accurate and consistent measurement of cancer lesions in CT
images to clinical care has been well documented (Erasmus et al., 2003; Gietema et al.,
2006; Hopper et al., 1996; Jiang et al., 2017; A. McErlean et al., 2013; Oxnard et al., 2011;
Posso et al., 2016; Singh, Pinsky, et al., 2011; Skougaard et al., 2012; Suzuki et al., 2010;
Vos et al., 2003; Wang et al., 2008; B. Zhao et al., 2009). Most studies investigating the
inter-observer measurement variability are observational studies in lieu of interventional
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studies. Our research was an exception as we conducted an interventional simulation-based
study aimed at reducing inter-observer variability in the measurement of lung lesions and
hepatic metastases in CT imaging. We employed a tailored peer benchmarking tool which
identified how peer-participants (radiologists) measured each lesion.
In a controlled environment, our tailored intervention presented no consistent
influence on inter-observer variability in measurement of lung lesions or hepatic metastases
by clinician participants. While our intervention was strategically presented and provided
each clinician participant with key information to influence his or her measurement
deviation, our findings reaffirm the notion that the availability of an intervention tool does
not necessarily result in its immediate effect. Despite the disparity, our results suggest
meaningful empirical relationships: (1) between measurement deviation and clinician
participant acceptability of the intervention measurement tool (presented at T3) and (2)
between measurement deviation and their CT slice selection.
The greatest inter-observer measurement variability in our study was observed
when the outer margin of a CT image cancer mass was non-smooth and was disputed by
the clinician participants. This was documented through a low clinician participant
“clinical acceptability” of the peer benchmarking intervention tool-identified start-point,
axis, and end-point of how a lesion was to be measured. This clinical acceptability score
was significantly (p=0.011) associated with within-threshold and deviating measurements.
Specifically, a larger percentage of clinician participants were more likely to record withinthreshold measurements when the start-point, axis, and end-point of our intervention tools
were rated by the participant as clinically acceptable.
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The specific CT slice within each imaging set selected by the clinician participants
when measuring the lung lesions and hepatic metastases mattered. The CT slice selection
(same or different from the majority of clinician participants) was significantly (p=0.045)
associated with within-threshold or deviating measurements. Specifically, the participants
who selected the same CT slice as the majority were more likely to record within-threshold
measurements than those who selected CT slice images different from the majority.
We observed no statistical association between time measured from image
presentation to recording a measurement and measurement deviation. This may, or may
not, be related to the observation that all clinician participants were experienced
radiologists.
All radiologists produced within-threshold measurements in the majority of the
cases. However, the presented statistic on individual performance does not necessarily
guarantee reduced risk associated with the inter-observer measurement variability. As
demonstrated in Table 5.1, the minimum and maximum percent difference in
measurements was higher than 20% in most cases with the maximum percent difference of
42% in hepatic metastasis 5. The percent difference of 42% in measurement between two
radiologists may interfere with the application of RECIST 1.1 criteria with a progression
defined as a 20% increase in the sum of longest tumor diameters, when a patient is
transferred from one radiologist to another; our results indicated that a patient with
completely stable disease can be misdiagnosed as partial response or progressive disease
in rare cases when the inter-observer variability is substantial.
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However, given that intra-observer variability is generally lower than interobserver variability (Hopper et al., 1996; Katherine M. Krajewski et al., 2014; A. McErlean
et al., 2013), the risk associated with inter-observer variability can be largely mitigated
when a single reader or group of the same readers produce measurements. While very few
studies recommended radiologists to re-measure the target lesion on the prior study
(Hopper et al., 1996), the risk may be addressed if the indicator lesions on the previous and
on the follow-up CT scans are re-measured by the interpreting radiologist.
A potential limitation of the study may arise due to the CT case selection process.
Although eligible cases were randomly pooled from the PACS, application of the selection
criteria was performed by one senior radiologist. The selection criteria included whether
or not a case is measurable under RECIST 1.1 criteria and commonly encountered in daily
clinical practice, which may have introduced a bias towards the case selection. Another
potential limitation is that the measurements were collected under a more controlled
environment than actual clinical practice. Throughout the data collection, the readers were
rarely interrupted. It has been documented in the literature that in certain clinical
environments (e.g. emergency room, intensive care units) that, when the workload is high,
task interruptions and workload can interfere with performance.
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Conclusion

In a controlled research study, there was no immediate change in the measurement
deviation of clinician participants through the presentation of a tailored peer benchmarking
intervention tool. The measurement deviation among experienced radiologists is
influenced by systematic bias, including clinician’s preference for selection of CT slice
(within a given imaging set), start point, longest axis, and end-point of measurement.
If future interventional efforts targeting measurement variability are to include a
peer benchmarking intervention tool, there is a need for additional research to understand
how one’s diagnostic behavior can be characterized (e.g. typically under-measure or overmeasure) within the study design and how clinical disagreement among radiologists can be
systematically measured and resolved in an interactive approach.
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Figures
Figure 5.1. Flowchart of the intervention.
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Figure 5.2. Example of individualized feedback generated from the peer benchmarking
intervention tool. Each horizontal line with arrow represents different CT slice and the
vertical dotted line in green represents median measurement value for each lesion. The
light green area represents plus and minus 10% interval from the median measurement
value. The horizontal axis represents magnitude of measurement with increment toward
right. The presented figure indicates that measurements performed by radiologist 5 (in
red) constantly underestimated the size of lung lesion 3 when compared to peers.
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Figure 5.3. Distribution of CT image slice choice and measurement in selected cases.
Each horizontal line with arrow represent different CT slice and the vertical dotted line in
green represents median measurement value for each lesion. The light green area
represents plus and minus 10% interval from the median measurement value. The
horizontal axis represents magnitude of measurement with increment toward right. Red
and blue dots are from session 1 and 2, respectively.
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Figure 5.4. Example of disagreement among radiologists in this study. The controversy
was associated with whether outer margin should be included or not in the lesion
measurement. Since the outer margin was included in the presented peer benchmarking
intervention tool, 53.8% of participants who excluded the outer margin in their
measurement expressed disagreement.
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Figure 5.5. Presented visual of sample measurements based on the fixed numeric value
of the weighted average and disagreement rates. Readers who agreed that the presented
measurement is clinically acceptable are considered as ‘acceptable’ and otherwise
‘unacceptable’.
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Tables
Table 5.1. Descriptive statistics for lung lesions and hepatic metastases

Note: Average measurement, weighted average of peer measurements, and range are in centimeters (cm). S.D. denotes
standard deviation. Min denotes minimum measurement for each lesion during T1, T2, and T3. Max denotes maximum
measurement for each lesion during T1, T2, and T3. Percent difference between minimum and maximum values was
calculated using the following formula: difference(min, max) / average(min, max). Range consists of (minimum
observed value – maximum observed value).
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Table 5.2. Individual performance evaluated by frequency of producing within-threshold
measurement and time spent per case

Radiologist

Average Time
(sec)

Frequency of producing within-threshold
measurement
T1

T2

T3

1

29.4

10/10 (100%)

10/10 (100%)

9/10 (90%)

2

26.2

5/10 (50%)

8/10 (80%)

7/10 (70%)

3

16.1

10/10 (100%)

9/10 (90%)

6/10 (60%)

4

21.7

10/10 (100%)

8/10 (80%)

9/10 (90%)

5

27.0

9/10 (90%)

8/10 (80%)

9/10 (90%)

6

28.2

8/10 (80%)

6/10 (60%)

8/10 (80%)

7

18.2

6/10 (60%)

5/10 (50%)

9/10 (90%)

8

25.3

7/10 (70%)

9/10 (90%)

7/10 (70%)

9

29.0

6/10 (60%)

6/10 (60%)

7/10 (70%)

10

23.2

7/10 (70%)

6/10 (60%)

10/10 (100%)

11

30.0

8/10 (80%)

8/10 (80%)

9/10 (90%)

12

32.1

9/10 (90%)

8/10 (80%)

8/10 (80%)

13

14.3

9/10 (90%)

9/10 (90%)

9/10 (90%)

All radiologists

24.7

p-value

104/130
100/130
107/130
(80%)
(76.9%)
(82.3%)
T1 vs. T2 vs. T3: Not Significant*
T1 vs. T2: Not Significant†

*p-value was calculated using Cochran’s Q test using all measurements from each session
†p-value was calculated using McNemar’s test using measurements from session 1 and 2.
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Table 5.3. Mixed-effects logistic regression model for the interaction between study
variables and measurement performance
Fixed Effects

Estimate

SE

z-value

Pr (>|z|)

(Intercept)
Slice Choice

-1.03
1.57

0.81
0.44

-1.27
3.54

0.20
<0.001*

Time Spent
(< 15 seconds)
Session
2
3
Clinical
Agreement
CT Scan
2
3
4
5
6
7
8
9
10

0.01

0.01

0.76

0.45

0.27
0.39
1.00

0.34
0.34
0.41

0.79
1.16
2.43

0.43
0.25
0.015*

-0.69
-1.59
0.99
-0.60
0.96
1.71
-0.59
0.13
0.66

0.62
0.61
0.67
0.62
0.67
1.37
0.64
0.63
0.80

0.26
0.01
0.14
0.33
0.15
0.99
0.36
0.83
0.41

0.26
0.01*
0.14
0.33
0.15
0.99
0.36
0.83
0.41

Note: Clinician participants evaluated the clinical acceptability of the presented sample measurement solely based on
start point, longest axis, and the end point.
*statistically significant
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CHAPTER SIX
PAPER 3: “A DEEP-LEARNING FRAMEWORK FOR CLINICAL DECISION
SUPPORT SYSTEM REDUCING INTER-OBSERVER VARIABILITY IN CT
TUMOR MEASUREMENT”

Abstract

Background
Performing Response Evaluation Criteria in Solid Tumor (RECISTS) measurement is a
non-trivial task requiring much expertise and time. A deep learning-based algorithm has
the potential to assist with rapid and consistent lesion measurement. The aim of this study
is to develop and evaluate deep learning (DL) algorithm for semi-automated
unidirectional CT measurement of lung lesions.

Methods
This retrospective study included 1617 lung CT images from 8 publicly open datasets. A
convolutional neural network was trained using 1373 training and validation images
annotated by two radiologists. Performance of the DL algorithm was evaluated 244 test
images annotated by one radiologist. DL algorithm's measurement consistency with
human radiologist was evaluated using Intraclass Correlation Coefficient (ICC) and
Bland-Altman plotting. Bonferroni's method was used to analyze difference in their
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diagnostic behavior, attributed by tumor characteristics. Statistical significance was set at
p<0.05.

Results
The DL algorithm yielded ICC score of 0.959 with human radiologist. Bland-Altman
plotting suggested 240 (98.4%) measurements realized within the upper and lower limits
of agreement (LOA). Some measurements outside the LOA revealed difference in
clinical reasoning between DL algorithm and human radiologist. Overall, the algorithm
marginally overestimated the size of lesion by 2.97% compared to human radiologists.
Further investigation indicated tumor characteristics may be associated with the DL
algorithm’s diagnostic behavior of over- or under-estimating the lesion size compared to
human radiologist.

Conclusion
The DL algorithm for unidirectional measurement of lung tumor size demonstrated
excellent agreement with human radiologist. Future studies may need to address interobserver variability between radiologists who train, validate and test the algorithm.
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Background

Response evaluation of cancer therapeutics is often prerequisite to various clinical
decisions in cancer treatment. Response Evaluation Criteria in Solid Tumor 1.1 (RECIST
1.1) is the predominant clinical guideline to determine whether tumors in cancer patients
improved (respond to treatment), stay the same, or worsened during cancer therapeutics
(Elizabeth A Eisenhauer et al., 2009; Lawrence H Schwartz, Saskia Litière, et al., 2016;
Lawrence H Schwartz, Lesley Seymour, et al., 2016; Patrick Therasse, Eisenhauer, &
Verweij, 2006). Application of RECIST guideline involves a series of tumor size
measurements, which is an important surrogate marker of therapeutic efficacy.
Throughout the decision-making process, clinicians are heavily dependent on a series of
anatomic measurements of targeted lesions. Consistent and accurate measurements of
tumor size are essential as they have a direct impact on cancer treatment and
management.
Performing RECISTS measurement is a non-trivial task requiring a great deal of
expertise and time by a highly trained radiologist. Multiple reports have indicated that the
tumor size measurements using computed tomography (CT) scans are subjected to intraand inter-observer variability with various environmental factors causing the variability
(Coy et al., 2019; Jiang et al., 2017; Aoife McErlean et al., 2013; Singh, Maxwell, et al.,
2011; Sosna, 2019; M. Woo, S. C. Lowe, A. M. Devane, & R. W. Gimbel, 2020; Yoon,
Kim, Goo, Kim, & Hahn, 2016). To address these challenges, researchers have attempted
to develop systems to assist with consistent lesion measurement through automated lesion

79

segmentation or masking for CT images (Brown et al., 2013; Chlebus et al., 2018; Hirata
et al., 2014; Meier et al., 2016; Tang, Harrison, Bagheri, Xiao, & Summers, 2018;
Vorontsov et al., 2019). Most studies used segmentation techniques with probabilistic
approaches to drawing lesion boundaries. However, segmentation results are often noncomparable to radiologist measurements as radiologists use unidirectional measurement.
Conversion of segmentation results into unidirectional measurement poses challenges as
the task requires additional clinical reasoning to decide the start point, end point, and
longest axis of the measurement, Figure 6.1. Performing segmentation often takes longer
than performing unidirectional measurement by human radiologists; this incurs additional
costs on the acquisition of training data for any automated system for segmentation.
In this study, we propose a new approach for application of a deep learning (DL)
algorithm on semi-automated CT measurement of lung lesions. To the best of our
knowledge, this study was the first to propose semi-automated measurement of tumor
without involving segmentation or masking process. The purpose is to develop a tool
performing measurement comparable to radiologist measurement, which has a potential
to assist radiologists with accurate RECIST annotation by improving both precision and
accuracy at a single measurement level. We also investigated how different lesion types
challenge the proposed application of the DL algorithm.
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Methods

Image Data Sets
We reviewed 8 publicly open datasets with 146,403 lung CT images from various
institutions (Table 6.1) (Aerts et al., 2016; Albertina et al., 2017; Armato III et al., 2016;
Clark et al., 2013; Consortium, 2018; Goldgof et al., 2017; Grove et al., 2015; Yang et
al., 2017; Binsheng Zhao, Schwartz, & Kris, 2015). A total of 1617 lung CT images were
included in this study after applying the following inclusion criteria: (a) lesion of interest
measurable under RECIST 1.1 (b) selected image file contains complete Digital Imaging
and Communications in Medicine (DICOM) pixel data with no corruption (c) lesion
pattern is largely different from the previously selected images if selected from the same
patient (d) selected image has at least 5mm spacing to the previously selected images if
selected from the same patient. Additionally, DICOM metadata relevant to image
processing (e.g. pixel spacing, window/level settings) was inspected for all selected
image files.

Reference RECIST Measurements
Three experienced board-certified radiologists who regularly perform treatment response
evaluation participated in training and evaluation of the proposed DL algorithm, Figure
6.2. Radiologist 1 (blinded for review) selected CT images for the study according to the
eligibility criteria. The 1617 CT images selected by the Radiologist 1 were randomly
assigned to training set, validation set, and test set through dataset-wise block
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randomization, Table 6.1. The following ratio was used as suggested in the potentially
relevant studies using deep learning: 70% training, 15% validation, 15% test (Chang et
al., 2020; Tabibu, Vinod, & Jawahar, 2019; Willemink et al., 2020). Radiologist 2
(blinded for review) and Radiologist 3 (blinded for review) performed measurement on
images from the training and validation sets, resulting in the exclusion of additional 18
images due to inter-observer variability regarding the measurability on the images
initially selected by Radiologist 1. The test set was labeled by Radiologist 1. For clarity,
there was no overlap between training and test data. The radiologist who labeled the test
dataset was ruled out during the training process. The participating radiologists did not
have access to measurements performed by other radiologists to prevent observer bias.
The reference measurements were performed between October 2018 to June 2019.

Semi-automated Measurement Using Deep Learning Algorithm
The DL network for automatic lesion measurement consisted of three consecutive
convolutional neural networks that labeled whether the size of a target lesion in a given
image frame was larger or smaller than 32 pixels. We assumed that, if the DL network
failed to classify, the failure occurred because the lesion size approximated to 32 pixels.

The training data preparation was performed by resizing each CT image so that its target
lesion would have a size of 32 pixels. The unidirectional measurements in centimeters
were converted into measurements in pixels (𝑀/0 ). The images were then magnified by
32/𝑀/0 times using bicubic interpolation as a differentiable sampler for the different

82

magnifications (Amruta, Gole, & Karunakar, 2010; Keys, 1981). Each target lesion was
cropped in a 128-by-128 pixel frame using the center point of measurement as a frame
center. The training dataset was generated through image augmentation techniques
including zooming in/out, horizontal/vertical shifting of the target lesion in an image
frame. Using the various magnifications, the DL network was trained to predict whether a
lesion in a 128-by-128 pixel frame is larger or smaller than 32 pixels. The augmentation
was also intended to improve the resilience of classification by training the DL algorithm
with target lesions off the center of the image frame (Shorten & Khoshgoftaar, 2019).
The convolutional neural network was trained for 500 iterations with a batch size of 32;
the model with the highest validation accuracy was selected. The proposed method was
semi-automatic; the algorithm was first given with an arbitrary point within a target
lesion to perform the RECIST measurements. Once the arbitrary point was acquired, the
algorithm utilized the point as a frame center to cropped 128-by-128 pixel image frames
containing target lesion with various magnifications, Figure 6.3.
Upon identification of magnification where the classification failed, a numerical value of
measurement was calculated using the magnification and DICOM pixel spacing tag. The
codes are available at https://github.com/minjaewoo/Semiautomated-CT-Measurement.

Statistical Analysis
Reliability of measurements by the DL algorithm was assessed with the intraclass
correlation coefficient (ICC) between automatically and manually obtained
measurements for images from the test set. The ICC was calculated using a two-way
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random-effects model that characterized absolute agreement to account for both lesionwise effect (target effect) and radiologist-wise effect (rater effect) for evaluation
comparable to the previous studies on inter-observer variability in CT measurement
(Aoife McErlean et al., 2013; Patrick E Shrout & Joseph L Fleiss, 1979).

Bland-Altman plotting with 95% limits of agreement was produced by averaging lesion
size between the human reader and DL algorithm to demonstrate the agreement between
the measurements produced by the human reader and DL algorithm (Sandstedt et al.,
2020). The percentage differences in measurement between the human and algorithm
were visualized in a histogram, Figure 6.4.

Additional statistical analyses were performed to identify the effect of lesion invasion
type on variability between the human radiologist and the DL algorithm. Bonferroni's
method was used for pairwise comparison of measurement difference by type of tumor
invasion. Statistical significance was set at p<0.05.

Results

Characteristic of Data Sets
Mean ages of patients in the training, validation, and test sets were 66.9, 66.1, and 67.1,
respectively, Table 6.1. Gender information extracted from DICOM metadata suggested
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more male (62%) than female (38%) representation in selected CT images. Average
lesion sizes annotated by the human radiologists for training, validation, and test sets
were 3.08cm, 3.26cm, and 2.99cm, respectively. As intended, Radiologist 1 annotated
244 images from the test set. Radiologist 2 and Radiologist 3 performed measurements
on training and validation sets, which resulted in 903 and 470 images annotated by
Radiologist 2 and Radiologist 3, respectively. The proposed data augmentation resulted
in a total of 142,254 images for training. The augmented training data included 71,127
images with lesion size smaller than 32 pixels and 71,127 images with lesion size larger
than 32 pixels within a 128-by-128 pixel frame.

DL Algorithm Performance
The DL algorithm achieved an ICC score of 0.959 (95% CI: 0.947, 0.967) with
Radiologist 1 when performing measurements on the same set of 244 CT images. BlandAltman plotting revealed a mean percent difference (systematic difference) of 2.97%
between human and DL algorithm; overall, the algorithm marginally overestimated the
size of lesion by 2.97% compared to human radiologists. Bland-Altman upper and lower
limits of agreement (LOA) were realized at 24.3% and -20.7%. The plot also revealed a
total of 6 measurements outside the lower and upper LOA. We have identified 4 lesions
that caused substantial measurement difference between the DL algorithm and human
radiologist; there were two lesions above upper LOA with 48.5% and 70.6%
measurement difference, and two lesions below lower LOA with 45.4% and 48.6%
measurement difference. The lesions that caused the outlier measurement difference
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between human and DL algorithm were presented and compared in Figure 6.5. For
technical details on how the start point, end point, and longest axis were determined for
the presented measurements by DL algorithm, see Supplemental Material 6.1.

The first lesion underestimated by the DL algorithm (Figure 6.5a) was subject to
controversy on whether its spiculations should be included in the measurement or not.
This particular case highlighted the inherent difficulty in measuring lung lesion as well as
lesion in other organs, as there is no clear consensus existing with regard to how the
spiculations should be taken into account in lesion measurement. In the second
underestimated lesion (Figure 6.5b), the clinical reasoning behind the underestimation by
the DL algorithm is unclear. The first overestimated measurement by DL algorithm
(Figure 6.5c) appeared to include the central density in its measurement while the density
was not included in the measurement by human radiologist. The controversy was
associated with whether the central density should be seen as a blood vessel or part of the
target lesion. In the second overestimated lesion (Figure 6.5d), the algorithm failed to
recognize two separate lesions sharing the same field of view and combined them into a
single measurement.

The Bland-Altman analysis indicated no heteroscedasticity issue; the visualization
suggested no evidence of increasing measurement difference between human and DL
algorithm with an increase in average measurement. A benchmark to test the performance
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of the DL algorithm indicated that performing a single measurement by the algorithm
takes on average of 2.2 seconds per lesion when tested on NVIDIA Jetson TX2 platform.

Effect of Invasion Type on Performance
Bland-Altman analysis suggested different diagnostic behavior between DL algorithm
and human radiologist when performing measurements; overall, the algorithm tended to
overestimate the size of lesion by 2.97% compared to human radiologists. However,
further comparisons stratified by tumor characteristics indicated that invasion type may
be associated with diagnostic behavior of the DL algorithm resulting in overestimation or
underestimation of lesion size. Specifically, a lesion-wise effect on the difference in
diagnostic behavior between human radiologist and DL algorithm was identified for the
following invasion type classification: (A) Parietal pleura/chest wall invasion (B)
Mediastinal pleural invasion (C) Endobronchial invasion less than 2cm distal to the
carina (D) Invasion associated collapse (atelectasis) (E) Peripheral invasion surrounded
by lung (F) Diaphragm invasion, Figure 6.6 (Choi et al., 2015). The Bonferroni pairwise
comparison suggested that the measurements by the algorithm are more likely to be
overestimated compared to human radiologist when measuring (B) tumor invading
mediastinal pleural and (D) tumor associated collapse (atelectasis) or obstructive
pneumonia, as compared to when measuring (C) endobronchial tumor less than 2cm
distal to the carina and (F) tumor invading diaphragm.
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Discussion

This was the first study to perform semi-automated measurements without masking or
segmentation process. The proposed algorithm facilitated the use of unidirectional
measurement throughout its training process, which significantly reduced the cost of data
acquisition. It yielded output comparable to a human radiologist’s standard RECIST
measurement used in daily clinical practice. The proposed methodology has the potential
to assist other anatomic measurements with known distance from patient to detector.

The inter-observer agreement rate between the DL algorithm and human radiologist was
0.959 when evaluated using ICC. Its performance is consistent with previously published
study by McErlean in which 17 radiologists measured the same 320 lesions to evaluate
inter-observer variability and achieved ICC scores of 0.943 and 0.967 among fellow and
junior attending radiologists, respectively (Aoife McErlean et al., 2013). The proposed
DL algorithm achieved an ICC score comparable to junior attending radiologists from the
study when measuring the same set of 244 lesions. In a study by Tang et al, a
convolutional neural network-based method for semi-automated RECISTS measurement
was proposed and assessed using a mean difference between DL algorithm and
radiologists in the unit of pixels (mean difference: 3.33 pixels; standard deviation: 4.93
pixels) (Tang et al., 2018). Our model achieved a mean pixel difference and standard
deviation of 2.85 and 2.51, which are 14% and 51% lower than the performance
suggested by the study, respectively. However, the score using pixel difference may not
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be a reliable measure as the score is largely affected by the composition of the dataset;
when a percent measurement difference between readers is fixed, having a larger number
of larger lesions may inflate the performance score of DL algorithm. For example, given
a pixel spacing of 0.1 and a lesion size of 5cm, the measurement difference of 5 pixels
accounts only 10% measurement difference between two readers. On the contrary, given
a pixel spacing of 0.1 and a lesion size of 2cm, the measurement difference of 5 pixels
accounts 25% measurement difference between two readers. In this study, we primarily
used Bland-Altman plotting based on percent measurement difference to address the
issue.

Bland-Altman plotting suggested that the proposed algorithm generally yielded
comparable measurements to a human radiologist with 240 (98.4%) measurements
realized within the upper and lower limits of agreement (LOA). Among the 4 (1.6%)
measurements outside the LOA, we observed that 2 deviating measurements potentially
subject to controversy among human observers, with some radiologists accepting the
measurements and others rejecting them. There was one case where the DL algorithm
included two separate but adjacent lesions into a single measurement, resulting in the
overestimated measurement outside the LOA. This may have been due to the absence of
similar cases in the training dataset. Lastly, we observed one underestimated
measurement outside the LOA with no clear clinical reasoning behind the measurement.
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We have further explored the DL algorithm’s diagnostic behavior through assessment of
the measurement by lesion-wise characteristics. It was observed that some tumor invasion
types may be associated with the DL algorithm’s diagnostic behavior of over- or underestimating the lesion size compared to human radiologist. The lesion size measurement of
some invasion types requires different clinical reasoning highly prone to inter-observer
variability. The systematic difference attributed by the lesion-wise characteristics may or
may not be due to inter-observer variability between the trainer and tester radiologists.

This study had some limitations. First, this was a semi-automated method as the
algorithm requires an arbitrary point within target lesion as an input. Future studies may
want to address the limitation by exploring a hybrid model that simultaneously detects
and measures a lesion by using negative training images (e.g. lesion larger than 32 pixels,
lesion smaller than 32 pixels, and not a lesion). Second, the study design did not account
for the potential intra- and inter-observer variability of human radiologists. Thus, it is
unclear whether a deviating measurement by DL algorithm is due to the intrinsically
challenging nature of the task or inter-observer variability between the radiologists who
labeled the training images and the radiologist who labeled the test images. Future studies
on a more efficient structure of DL networks for the proposed algorithm may be
warranted. To the best of our knowledge, no study utilized an algorithm that intentionally
fails DL networks to perform a measurement. The distinctive peculiarity of the algorithm
may require unconventional structure of DL networks for optimal performance.
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Conclusion

This study proposed and validated a deep learning algorithm for semi-automated CT
measurement of lung lesions. The DL algorithm yielded unidirectional measurements
comparable to those of human radiologist and presented an excellent agreement. The DL
algorithm was designed to work with any image with known patient-to-detector distance,
indicating a potential for its application in other anatomic measurements.
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Figures

Figure 6.1: Challenges associated with lesion segmentation and its conversion to
unidirectional RECIST measurement. (a) Automated lesion measurement is challenged
by the absence of visual distinction between beginning and ending points and their
surrounding areas. (b) Lesion boundaries are visually distinct and well-defined; both
segmentation and conversion of segmentation into measurement can easily be automated
using existing techniques and tools. (c) Both segmentation and conversion of
segmentation into measurement require a significant amount of clinical reasoning, which
poses challenges to the idea of automated measurement through segmentation.
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Figure 6.2: Flow diagram illustrating data collection procedures and inclusion criteria.
The inclusion criteria were designed to ensure heterogeneity of lesion patterns in the
collected data. Each radiologist independently performed the measurements. The
participating radiologists were blind to the measurements performed by other
radiologists.

Lung CT scans from open databases
(8 databases; 1228 scans; 146403 images)

Radiologist 1
244 images reviewed
244 images annotated
0 images excluded

144786 images excluded by Radiologist 1

1635 images selected

Inclusion criteria:
1. Complete DICOM pixel data with no corruption
2. A lesion of interest measureable under RECIST 1.1
3. (If selected from the same patient) A lesion pattern
largely different from the previously selected images
4. (If selected from the same patient) At least 5mm
spacing to the previously selected images

Radiologist 2
484 images reviewed
470 images annotated
14 images excluded

Radiologist 3
907 images reviewed
903 images annotated
4 images excluded

Randomization (244/1129 images)

Test set (n=244)

Validation set (n=244)

Training set (n=1129)
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Figure 6.3: Overview of deep learning algorithm to perform unidirectional lesion
measurement. In the shown example, the input image was augmented into 16 images at
various magnifications, using the arbitrary input point (stained in red, pointed by arrow)
in the target lesion. The neural network classified each augmented image whether the
containing lesion size is larger or smaller than 32 pixels within a 128-by-128 pixel frame.
Upon identification of a magnification inducing classification failure, the magnification
and pixel spacing information were used to determine the final measurement.
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Figure 6.4: Bland-Altman plot and histogram illustrating measurement difference
between human radiologist and DL algorithm. Each data point in Bland-Altman plot
represent measurement difference between human radiologist and DL algorithm over the
)
'∙(3456784349: < 3456784349:
same lesion, calculated by the following formula: (3456784349: !"> 3456784349: #$%&') .
!"

#$%&'

The limits of agreement are represented in the dotted line, calculated by the following
formula: ±1.96 ∙ 𝑆𝐷. The horizontal solid lines represent systematic difference in BlandAltman plot and histogram.
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Figure 6.5: Example of outlier measurement differences from Bland-Altman plot. (a)
The lesion underestimated by DL algorithm was subject to controversy on whether its
spiculations should be included in the measurement or not. (b) The lesion was
underestimated by DL algorithm with no clear clinical reasoning behind the
measurement. (c) The lesion was overestimated by DL algorithm as the central density
was included in the measurement (d) The lesion was overestimated by DL algorithm as
the algorithm was interfered by two separate lesions sharing the same field of view.

Underestimated DL Measurement
Radiologist
DL Algorithm

Overestimated DL Measurement
Radiologist
DL Algorithm

(a)

(c)

Radiologist

DL Algorithm

Radiologist

DL Algorithm

(d)

(b)
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Figure 6.6: DL algorithm’s measurement error by tumor invasion type. The
measurement error was calculated by using the following formula:
'∙(3456784349:!" < 3456784349:#$%&' )
.
(3456784349: > 3456784349:
)
!"

#$%&'

The invasion types were classified as follows: (a) Parietal pleura/chest wall invasion. (b)
Mediastinal pleural invasion. (c) Endobronchial invasion less than 2cm distal to the
carina. (d) Invasion associated with collapse (atelectasis). (e) Peripheral invasion
surrounded by lung. (f) Diaphragm invasion. Box plots show the distribution of percent
measurement errors stratified by invasion type. Bonferroni multiple comparison was
performed, with statistical significance defined as *P<0.05.

ⓐ
ⓑ

ⓒ

ⓓ
ⓔ

ⓕ
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Tables
Table 6.1. Characteristics of Data Sets
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Table 6.2. Reader statistics and inter-observer variability between human radiologist and
DL algorithm
Reader
Radiologist 1
Radiologist 2
Radiologist 3
DL Algorithm

Image Use

Number of Annotated Images

Average Measurement (cm)

Test

244

2.99 ± 0.93 (1.57–4.91)

Training

734

3.17 ± 0.96 (1.51–5.00)

Validation

159

3.21 ± 0.98 (1.50–4.99)

Training

395

2.92 ± 0.88 (1.49–4.94)

Validation

85

3.35 ± 0.89 (1.56–4.79)

Test

244

3.07 ± 0.91 (1.37–5.44)

Radiologist 1 & DL Algorithm ICC: 0.959 (95% CI: 0.947, 0.967)
Note – Average Measurement ± Standard Deviation. Numbers in parentheses represent range
consisting of (minimum observed value – maximum observed value). ICC denotes intraclass
correlation coefficient. The ICC score is based on a two-way random-effects model. CI denotes
confidence interval.
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Supplemental Material

Supplemental Material 6.1
The presented DL algorithm offered only the numerical value of tumor size
measurement. Additional image processing techniques were used to determine the
following information for visualization purposes: (a) axis of measurement (b) either start
or end point (i.e. vertex) of measurement.

- Axis of Measurement
The acquisition of the longest measurement axis was performed using image rotation and
compression . The axis acquisition was based on idea that when the compression axis
perfectly aligns with true measurement axis, there should be no change in the longest
measurement value as a result of compression. Likewise, if the compression axis
approximates to the true measurement axis, there should be minimal change in the
longest measurement value after compression.

Supplemental Figure 6.1. Example of effect of different compression axis on
measurement value.
As an example, when true measurement axis approximates to vertical axis, the numerical
value of the longest measurement does not change significantly when lesion image is
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compressed horizontally using vertical compression axis, Supplemental Figure 6.1. On
the contrary, the numerical value of the longest measurement decreases significantly
when vertical compression (i.e. horizontal compression axis) is used due to the
discrepancy between the true measurement axis and compression axis.
Images containing target lesion were rotated from 0 to 360 degrees with increment of 3
degree. The vertical compression was performed on the rotated images to find images
which yield the maximum numerical value of measurement after the compression,
Supplemental Figure 6.2.
Effect of Compression on Measurement
4

Measurement (cm)

3.5
3
2.5
2
1.5
1

180°

0.5
0
0

30

60

90

120

150

180

210

240

270

300

330

360

Compression Axis (°)

Supplemental Figure 6.2. Compression at various angles and the corresponding
measurement. The images were rotated, horizontally compressed, and measured to
identify compression axes minimally affecting the numerical value of measurement.
Using scatter-plot of compression axis and the corresponding measurement value, a pair
of images apart from each other by approximately 180 degrees and yielding the largest
numerical value of measurement were identified. Since their compression axis had a
minimal effect on the numerical value of measurement, the axis was selected as the
longest measurement axis for the visualization.
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- Measurement Vertex
The measurement vertex was acquired using some basic masking and vector shape
building techniques.

Supplemental Figure 6.3. Use of masking concave hull to identify start point of
measurement. Masking based on Canny edge detector was performed around the arbitrary
input point inside the target lesion. A point yielding the longest measurement for the
given fixed axis was selected as the start point of measurement.

First, the Canny edge detector was used to segmentize the anatomic structures adjacent to
the given arbitrary point locating inside the target lesion, Supplemental Figure 6.3. The
segmentation resulted in a set of boundaries including both lesion and non-lesion areas in
the field of view. Given the axis of the longest measurement, a pair of points which locate
on the boundary and yield the longest possible measurement crossing the segmentized
area was selected. A single point locating close to the center of mass based the
segmentation was selected as a vertex of the longest measurement for the visualization.
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CHAPTER SEVEN
DISCUSSION
Overview of Study Findings and Strengths

This dissertation work had three major aims: 1) To propose a new approach that
offers precision in evaluation of the inter-observer variability as well as actionable
thresholds on how the inter-observer variability can be addressed in daily clinical practice,
2) To assess whether a peer benchmarking tool may have an influence on reducing the
inter-observer variability among experienced radiologists, and 3) To investigate whether
deep learning technology can offer a tool that supports radiologists when producing CT
measurements. These aims were achieved through a series studies incorporating manual
measurements observed in real-world clinical settings. The purpose of each study and the
corresponding results are summarized Table 7.1.

Table 7.1. Overview of study aims and the corresponding results
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The study on approaches to evaluate inter-observer variability in CT measurements
was the first study to perform an extensive simulation-based experiment to assess
conventional correlation coefficient measures in the context of radiologic measurement of
cancer lesions. Our study examined those widely used statistical measures and found that
some of them are not sensitized enough to detect the varying levels of inter-observer
variability in CT measurements. Furthermore, the use of the measures may result in a sense
of false security related to the measurement consistency, as they generally yield
considerably high scores regardless of the existing level of inter-observer variability among
observers.
The next study on utilizing peer-benchmark tool for intervention to reduce interobserver variability in CT measurements was the first interventional study which aimed to
reduce inter-observer variability among experienced radiologists. Although the
intervention did not result in a statistically significant improvement in the inter-observer
variability, the study demonstrated that the variability is primarily attributed to systematic
errors (e.g., different clinical opinion compared to peers) rather than random errors. The
study presented statistically significant association between factors relevant to one’s
clinical agreement and deviating measurements potentially aggravating inter-observer
variability.
Lastly, the study on the application of deep learning (DL)-based algorithm on the
semi-automated unidirectional measurement of lesion size was the first study to utilize a
binary deep learning classifier for size measurement of anatomic structure. The DL
classifiers are considered to be suitable for classification challenges only, as their response
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variables are either binary or categorical. The study presented a DL algorithm for the
automated lesion measurement which demonstrated impressive performance; the interobserver variability between human radiologists and the DL algorithm was lower than the
inter-observer variability between human radiologists when performing CT measurements
of the lung lesion. The algorithm is also readily available as a cost-effective data mining
tool for extracting tumor burden information from raw CT images, which typically requires
a considerable amount of resources such as physician time.

Limitations

Some important limitations were identified in the presented studies. First, one
potential limitation of the studies is the homogeneity of the clinician participants. They
were all experienced radiologists that had invested much of their professional careers
outside of academic medicine. The radiologists were not engaged in teaching radiology
residents or accustomed to clinical decision support tools aimed at supporting measurement
accuracy.
Another important limitation of the studies is that the measurements were collected
under a highly controlled environment where the participating radiologists were rarely
interrupted. It is well-known that in hectic clinical environments and when workload is
high, task interruptions and heavy workload can interfere with one’s performance.
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Similarly, the acceptability of clinical decision support tools by clinicians may vary in the
actual clinical environments.
Additionally, a potential limitation of the first two studies may result from the
image selection process. While the images for the studies were selected under the
predetermined selection criteria, application of the criteria was performed by one
radiologist, which may have introduced a bias in the selection process.
In the study presenting approaches to evaluating inter-observer variability in CT
measurement, the proposed measure utilizing the systematic percent difference to evaluate
dissimilarity between two radiologists is overly simple. While the interpretability was the
major motivation behind the proposed measure, there is a necessity for a new statistical
measure that is interpretable, responsive, and capable of quantifying the measurement
similarity between two radiologists in a more realistic manner.
Lastly, in the study presenting and assessing DL algorithm for the semi-automated
CT measurements, the study design did not account for the potential intra- and interobserver variability of human radiologists who labeled training or test dataset. For this
reason, it remains unclear whether a deviating measurement by DL algorithm when
compared to human radiologist occurred due to the algorithm malfunction or inter-observer
variability between the training and testing radiologists. Also, unlike many DL algorithms
that are relatively well-known and available for various applications, it was not possible to
optimize structure of the proposed algorithm due to its distinctive peculiarity. There is
currently no comparable DL algorithm that can be referred for the optimization of the
proposed algorithm.
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Future Studies

There is a need for additional research to understand how the measurement
similarity between two radiologists can be better quantified in real-world clinical settings,
which may offer a new statistical measure that is more responsive and interpretable when
evaluating the inter-observer variability. In addition to the improved statistical measure for
the measurement similarity, future studies may consider adopting intervention strategies
utilizing assignment mapping based on the dissimilarity between pairs of radiologists to
reduce the inter-observer variability.
In response to the finding that clinical disagreements rather than random errors are
the basis of inter-observer variability, future studies may design interventions aiming to
resolve the disagreement among radiologists in an interactive manner. One’s diagnostic
behavior or clinical reasoning is built on years of experience; any intervention to affect the
behavior or reasoning may require interventions conducted in a longer period.
The presented DL algorithm was a semi-automated method, as it requires an
arbitrary point within target lesion as an input. Future studies may want to address the
limitation by exploring a hybrid model that simultaneously detects and measures a lesion
by using negative training images. Such algorithm will fully automate the measurement
process by first identifying the potential target lesions and then perform the size
measurements of the identified lesions.
Additionally, future studies are warranted to investigate the impact of interobserver variability between human trainer and tester on the inter-observer variability
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between the DL algorithms and human testers. While the presented study indicates the
potential influence by the inter-radiologist variability on the algorithm performance, there
is still a need for hypothesis-driven studies with appropriate experimental design to draw
conclusions that are scientifically valid and have practical usability.
To the best of our knowledge, no study utilized an algorithm that intentionally fails
DL networks to perform a measurement. While the similar DL algorithm can be utilized to
work with any image with known patient-to-detector distance, the distinctive peculiarity of
the algorithm may require unconventional structure of DL networks for optimal
performance. Future studies are warranted to examine how different structures for the
algorithm affect its performance.
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